Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2007 Nov 30.
Published in final edited form as: Brain Cogn. 2007 Jul 10;65(1):47–68. doi: 10.1016/j.bandc.2006.02.008

Social neuroscience of child and adolescent depression

Anita Miller 1
PMCID: PMC2099694  NIHMSID: NIHMS31799  PMID: 17624647

Abstract

The social neuroscience of child and adolescent depression is inherently multidisciplinary. Depressive disorders beginning early in life can have serious developmental and functional consequences. Psychopathology research has described depression’s defining clinical and contextual features, and intervention research has characterized its response to treatment and prevention programs. Neuroendocrine, electrophysiological, and neuroimaging studies have identified core neurobiological aspects of early-onset mood disorders. These areas are reviewed using a developmental social neuroscience perspective for integrating disparate observations. The paper introduces a dynamic adaptive systems framework, and it discusses hedonic capacity, stress sensitivity, ruminative self-focus, and attentional impairments as fundamental components of mood disorders.


Neuroscience focuses on the intricate details of nervous system anatomy and physiology. Social development largely concerns how youngsters interpret contextual experiences, such as emotional events and interactions. Developmental social neuroscience integrates the elaborate details of neurobiology with the multifaceted context of childhood experiences. This multidisciplinary perspective can be particularly fruitful for understanding the early development of emotions and emotional disorders (Allen & Badcock, 2003; Cacioppo, 2002; Dahl, 2004; Davidson et al., 2002; Gunnar, 2003; Harmon-Jones & Devine, 2003; Nelson et al., 2002; Ochsner, 2004; Schmidt & Schulkin, 2000). The current paper focuses specifically on the social neuroscience of depressive disorders beginning during childhood or adolescence.

A growing scientific literature addresses the functional neurobiology of early-onset depressive disorders. Using neuroendocrine, electrophysiological, and neuroimaging assessments, investigators seek neurobiological correlates of depressive disorders, with the ultimate goal of disentangling the causes and consequences of the initial onset of affective illness. However, biological observations from isolated studies can be difficult to interpret, and findings across studies often vary. This paper argues that neurobiological studies of child and adolescent depression can benefit from a multidisciplinary research perspective that integrates not only principles of social neuroscience but also empirical findings from the clinical research literature. In particular, developmental psychopathology research has described the clinical and contextual features of early-onset depression, and intervention studies have characterized responses to prevention and treatment programs. After introducing the basic nosology of early-onset depression, this paper reviews relevant psychopathology, intervention, and neurobiological research. Although space constraints limit detailed methodological discussions of individual studies, the review emphasizes replicated empirical findings and notes fundamental research design principles. The paper then introduces a developmental social neuroscience perspective about early-onset depression. The central goal is to organize the fundamental features of depression in a manner that generates testable alternative hypotheses about relations among psychopathology, intervention, and neurobiology within a developmental framework.

Nosology of Child and Adolescent Depression

From a psychiatric diagnostic perspective, depressive disorders include a heterogeneous group of conditions, most of which have been recognized in children and adolescents since the late 1970s (see Cicchetti & Toth, 1998; Kovacs, 1997a). Before the late 1970s, sadness in youngsters was often assumed to be a transient emotional response to difficult circumstances that differed fundamentally from the syndrome of major depressive disorder in adulthood. Research in this area shifted fundamentally with the development and use of semi-structured interviews (Chambers et al., 1985; Hien et al., 1998; Sherrill & Kovacs, 2000) and the application of operational diagnostic criteria for depression in youths, as specified in the third and subsequent revisions of the Diagnostic and Statistical Manual of the Mental Disorders (DSM-III, DSM-IIIR, DSM-IV; APA, 1980, 1987, 1994). The current paper focuses specifically on studies that used such standardized diagnostic criteria for defining depression in youngsters.

The criteria for major depressive disorder in youths have remained essentially unchanged from the DSM-III through DSM-IV. Major depression is defined by a combination of protracted dysphoria, anhedonia, or irritability along with a cluster of other symptoms including dysregulated sleep (e.g., insomnia, hypersomnia, fatigue), eating (e.g., appetite change, weight loss, failure to make expected weight gains), motor behavior (e.g., psychomotor retardation, agitation, or restlessness), thought (e.g., distractibility, indecisiveness, hopelessness), and self-esteem (e.g., feelings of worthlessness or guilt and suicidal ideation). To be diagnosed with major depression, a youth must have at least five such co-occurring symptoms for at least two weeks (APA, 1994). Dysthymic disorder is a symptomatically less severe but temporally more protracted form of depression. The criteria have changed significantly from DSM-III to DSM-IV. DSM-IV criteria require that depressed mood and two or more associated symptoms last for at least one year in youths, along with personal distress or functional impairment.

Depression can also present as a subthreshold, subsyndromal, or subclinical condition. In other words, the individual may experience dysphoric moods and associated symptoms (e.g., negative self-esteem, pessimism) that are more severe and numerous than the norm in his or her reference groups. Elevated symptom states often are identified with rating scales or questionnaires rather than semi-structured clinical interviews. Subsyndromal or mild depressive symptoms have been shown to increase risk for later major depressive episodes and functional impairment (Gotlib, Lewinsohn, & Seeley, 1995; Lewinsohn, Roberts, Seeley, & Rohde, 1994; Lewinsohn, Rohde, & Seely, 1998; Williams, Anderson, McGee, & Silva, 1990).

Most epidemiological data about rates of depression in youngsters pertain to major depressive disorder. Risk of major depression increases almost exponentially across development. According to epidemiological studies involving more than 2500 youngsters, approximately 2 percent of young children, roughly 4 percent of young adolescents, and at least 16 percent of older adolescents suffer from major depression each year (Anderson, Williams, McGee, & Silva, 1987; Feehan, McGee, Raja, & Williams, 1994; Harrington, Fudge, Rutter, Pickles, & Hill, 1990; Kessler & Walters, 1998; McGee et al., 1990; Newman et al., 1996; Weissman et al., 1996). These findings mean that about 1 in 50 young children, 1 in 25 young adolescents, and almost 1 in 6 older adolescents are depressed each year. During childhood, rates are higher in boys than girls, but during adolescence and after puberty, prevalence rates for girls become approximately twice those for boys (i.e., a 2:1 female-to-male ratio; Kessler, McGonagle, Swartz, Blazer, & Nelson, 1993; Lewinsohn, Hops, Roberts, Seeley, & Andrews, 1993). The U.S. lifetime occurrence of a depressive disorder between ages 15 and 24 years is 21 percent among females and 11 percent among males (Blazer, Kessler, McGonagle, & Swartz, 1994; Kessler et al., 1994).

Developmental Psychopathology

Developmental psychopathology research has identified the defining clinical and contextual features of early-onset depression. Although the specific context of particular studies contributes variability to empirical observations, growing consensus exists about the basic descriptive and epidemiological features of depressive disorders in youngsters. In particular, systematic empirical studies have characterized the longitudinal course of major depressive disorder and common patterns of comorbid psychopathology. The functional concomitants and developmental consequences have also been documented. Furthermore, much is known about the familial and psychological context in which depression develops in youngsters. In addition, studies are beginning to identify specific genetic and experiential risk factors, but basic questions remain about the details in this area. In general, several core patterns of convergence and divergence of depressive presentations across the lifespan are beginning to emerge, underscoring the need for researchers and clinicians to account for the unique developmental aspects of depressive disorders beginning early in life (Birmaher et al., 2004; Kaufman, Martin, King, & Charney, 2001; Yorbik et al., 2004).

Longitudinal Course

In longitudinal clinical studies of youngsters age 7 to 17 years, operationally defined major depressive episodes have a median duration of 7 to 9 months from onset to recovery (Kovacs, Finberg, Crouse-Novack, Paulauskas, & Finkelstein, 1984a; Kovacs, 1997b; McCauley et al., 1993). Most such youths recover in less than a year, but up to 20 percent have episodes lasting longer than 18 months, suggesting that a sizable minority have a more protracted clinical course. Likewise, youngsters with dysthymic disorder have a lengthy clinical course, with a median episode length of approximately four years and typical age at onset about three years earlier than major depression (Kovacs, 1996). Although almost 80 percent of youngsters with dysthymic disorder go on to develop major depression, very few youngsters who initially present with major depression develop dysthymia later (Kovacs et al., 1994).

From another perspective, almost 100 percent of depressed youngsters with a diagnosed depressive disorder ultimately get better. Among clinically referred youngsters, the cumulative proportion of recovery from a major depressive episode is 70 to 80 percent after one year and 86 to 98 percent after two years (Kovacs, 1996, 1997a, 1997b; McCauley et al., 1993). Yet, many become depressed again after symptomatic recovery. In one longitudinal nosological study, almost 40 percent of youths with major depression had a recurrent episode within two years (Kovacs et al., 1984b). Across longer time intervals of 7 to 18 years, recurrence rates of 40 to 70 percent are documented in 6-to-18-year-old clinical samples of depressed youths (n=417; Harrington et al., 1990; Hughes et al., 1990; Kovacs et al., 1994; McCauley et al., 1993; Weissman et al., 1997). In these studies, risk of recurrent depression exceeds risk for other disorders.

In addition, youngsters with a diagnosis of major depression are more likely than nondepressed youngsters to become depressed in the future (Kovacs et al., 1984b; Lewinsohn, Rohde, Seeley, Klein, & Gotlib, 2000), and dysthymic disorder or minor depression is often a precursor of major depressive disorder and functional impairments (Kovacs et al., 1994; Lewinsohn et al., 1991). Dysthymia typically occurs at an earlier age than major depression, and over 80 percent of dysthymic children later develop major depression (Kovacs, 1996). When followed into adulthood, approximately half of depressed adolescents from community samples have major depression in adulthood (Lewinsohn, Rohde, & Seeley, 1998), and about half of depressed young adults had their first episode as a child or adolescent (Newman et al., 1996).

In summary, systematic nosologic studies using standardized diagnostic criteria document that mood disorders that begin between ages 7 and 18 years are episodic, but often chronic, underscoring the fact that outcomes likely change over time. This observation establishes a strong rationale for the value of longitudinal evaluations in both research and clinical settings. Particular attention is needed for those depressed youngsters with incomplete recovery, relapse episodes, or recurrent episodes, as well as those who develop other disorders over time. Too many studies within emerging interdisciplinary areas such as social neuroscience fail to account for fundamental variability from well-established clinical features of depressive disorders. In order for interdisciplinary clinical neuroscience studies to yield replicable effects, the research must be anchored with rigorous standards for current and lifetime clinical diagnoses.

Comorbid Psychopathology

A striking and widely replicated characteristic of clinic-referred youngsters with major depression is that more than 90 percent of them also have other forms of psychopathology during their index episode, which complicates clinical diagnosis and treatment as well as research protocols (Angold & Costello, 1993; Kovacs, Gatsonis, Paulauskas, & Richards, 1989; Kovacs, Paulauskas, Gatsonis, & Richards, 1988; Mitchell, McCauley, Burke, & Moss, 1988; Puig-Antich, 1982; Rao et al., 1995; Ryan et al., 1987; Shain, King, Naylor, & Alessi, 1991). For example, dysthymic disorder co-occurs with major depression at rates of 13 to 40 percent (n=391), and anxiety disorders are present in 23 to 51 percent of depressed youths (n=208). Behavior disorders (i.e., conduct, oppositional, attention deficit disorders) occur in about one-fourth of depressed youngsters. As they get older, depressed youths are at increased risk for alcohol and drug abuse (Hughes & Preskorn, 1989; Hughes et al., 1990) as well as suicide (Brent, Baugher, Bridge, Chen, & Chiappetta, 1999). Approximately 70 percent of behavior and substance abuse problems that occur concomitantly with an initial episode of prepubertal-onset major depression remit with the depression, but a second episode is often preceded by disrupted behavior (Puig-Antich, 1982). Such uncoupling is particularly common in boys. In girls, comorbid disorders tend to co-occur with depressive episodes (Kovacs, Obrosky, & Sherrill, 2003).

Longitudinal follow-up studies have shown that a sizeable minority of pediatric clinical populations with major depression develop manic episodes and have a chronic bipolar variant of mood disorder. In bipolar disorder, depressive episodes are intermixed or alternate with manic symptoms, including extreme patterns of elevated, expansive, or irritable mood along with related symptoms such as hyperactivity, pressured speech, racing thoughts, inflated self-esteem, decreased sleep, distractibility, and impulsivity (APA, 1994). Reported rates of “switch” from unipolar to bipolar mood disorder in youngsters have generally been from 10 to 20 percent, but conversion rates above 30 percent have also been found in some clinical populations (Kovacs & Pollock, 1995; Geller, Zimerman, Williams, Bolhofner, & Craney, 2001a; Strober, Lampert, Schmidt, & Morrell, 1993). Variable findings may reflect difficulties with obtaining reliable retrospective reports and diagnoses of complex and changing symptoms over long time periods. In addition, community samples may have lower base rates of bipolar disorder than child psychiatric populations (Lewinsohn, Klein, & Seeley, 1995, 2000). Such observations underscore the need for social neuroscience studies of early-onset depression to document comorbid internalizing and externalizing disorders as well as manic episodes.

Functional Concomitants

The functional problems that characterize depressed youngsters suggest that the disorder can interfere with developmental milestones. For example, interpersonal problems and academic declines are common, along with delays in social, emotional, and cognitive development (Geller et al., 2001b; Kovacs & Goldston, 1991; Kovacs & Devlin, 1998; Puig-Antich et al., 1985a, 1985b). Interpersonal dysfunction is often characterized by low self-esteem, spending considerable time alone, and eliciting overt negative reactions from peers and adults (e.g., Altmann & Gotlib, 1988; Kovacs & Lohr, 1995; Messer & Gross, 1995). Intellectual problems are frequently marked by attentional difficulties that interfere with other cognitive tasks on standardized intelligence and neuropsychological tests (e.g., Brumback & Weinberg, 1990). In addition, negative outcomes of severe depression often include substance use (Rao et al., 1995), suicide attempts (Harrington et al., 1990, 1994; Kovacs, Goldston, & Gatsonis, 1993), and employment incapacity (Harrington et al., 1990). Such factors affect a youngsters’ clinical prognosis, particularly with protracted depression and marked developmental delays, and they can confound depression effects in psychological and biological studies of early-onset depression. Researchers should document and control for such possible confounds.

Familial Context

Family studies show that early-onset depression should be considered in relation to the history of depression in the larger family unit (Sheeber, Hops, & Davis, 2001). In studies of children with major depression, familial rates of mood disorders range from 35 to 70 percent in first-degree relatives and 10 to 25 percent in second-degree relatives (Kovacs, Devlin, Pollock, Richards, & Mukerji, 1997; Mitchell, McCauley, Burke, Calderon, & Schloredt, 1989; Neuman, Geller, Rice, & Todd, 1997; Puig-Antich, Goetz, et al., 1989; Todd, Neuman, Geller, Fox, & Hickok, 1993). Familial aggregation can be lower in adolescent-onset than childhood-onset depression, but rates for both groups exceed those of the controls (Klein, Lewinsohn, Seeley, & Rohde, 2001; Williamson et al., 1995). When the entire family was the unit of analysis in a longitudinal study of clinic-referred cases, 94 percent of depressed children with onset prior to age 15 years had affected pedigrees, with a 5:1 odds ratio of risk relative to controls (Kovacs et al., 1997). Substance abuse and conduct disorder/antisocial personality disorder are also common in family pedigrees with early-onset depression, particularly in male relatives (Rush et al., 1995). Such research suggests that familial psychopathology may account for significant variance among samples of depressed youngsters.

A positive family history of depression and discord increases risk for childhood-onset depression. Epidemiology studies have established that parental depression predicts offspring depression. In particular, children of depressed parents are 3 times more likely than non-psychiatric controls to develop major depressive disorder, with lifetime risk up to 45 percent (Downey & Coyne, 1990; Fendrich, Warner, & Weissman, 1990; Hammen, 1991; Jensen, Bloedau, Degroot, & Ussery, 1990; Kaminski & Garber, 2002; Orvaschel et al., 1988). In addition, family history appears essential for predicting recurrence. In one prospective study of depressed youngsters, those who developed recurrent depression during young adulthood also had a positive parental history of depression (Wickramaratne, Warner, & Weissman, 2000). In other words, depressed youngsters whose parents were never depressed did not differ from a healthy comparison group in their risk for major depression during adulthood. The study also documented that family history predicts recurrent depression more strongly when depression begins during childhood than during adolescence (Wickramaratne, Greenwald, & Weissman, 2000). Thus, young adults at highest risk for developing depression are those who have a family history of depression along with a personal history of depression beginning very early in life. Prospective studies of depressed youths with a high family loading support this notion (Williamson et al., 2004).

Genetic Studies

Genetic research also provides evidence for familial risk factors. Twin studies have documented heritability estimates that are twice as high for childhood-onset depression (79 percent; Thapar & McGuffin, 1994) than adult depression (30–46 percent; Jardine, Martin, & Henderson, 1984; Kendler, Heath, Martin, & Lindon, 1986). In addition, multi-generational studies identify patterns of increasingly severe and earlier age of onset across successive generations in families with recurrent unipolar depression (Engström et al., 1995; Ohara, Suzuki, Ushimi, Yoshida, & Ohara, 1998) or bipolar disorder (McInnis et al., 1993; Nylander, Engström, Chotai, Wahlström, & Adolfsson, 1994). This phenomenon, called “genetic anticipation”, often occurs in highly heritable disorders and has been associated with large trinucleotide repeats in molecular genetic studies (e.g., Vincent et al., 2000). However, limited cases of large trinucleotide repeats appear to exist in groups with childhood-onset depression (Vincent, Kovacs, Krol, Barr, & Kennedy, 1999). Segregation analyses suggest a recessive major effect with significant parental effects (Marazita et al., 1997). Some association studies of genetic variants, such as cyclic AMP responsive element binding protein (CREB1), have reported conflicting results (Burcescu et al., 2005; Zubenko et al., 2002, 2003).

Replicated molecular genetic effects related to early-onset mood disorders have been observed on chromosome 11p14, related to brain derived neurotrophic factor (BDNF; Strauss et al., 2004, 2005; see also, Schumacher et al., 2005). BDNF is a nerve growth factor involved in regulating cellular development, neuronal survival, synaptic plasticity, and stress resistance (Thoenen, 1995). Growing evidence implicates BDNF-dependent processes in the pathophysiology of depressive disorders and the therapeutic action of antidepressant treatments (Duman, 2002). However, functional outcomes of BDNF-dependent processes can be complex and paradoxical, with documented age-related changes and sexual dimorphisms (Bland et al., 2005; Mattson, Maudsley, & Martin, 2004; Scharfman & MacLusky, 2005; Tsai, 2005). Such observations suggest the intriguing hypothesis that neurobiological factors in early-onset mood disorders may be characterized not by static focal deficits but rather by variations in dynamic developmental brain mechanisms that are shaped by environmental inputs.

Psychosocial Studies

In psychosocial studies of familial risk factors, one of the most consistent findings is that family discord predicts negative outcomes in high-risk offspring of depressed parents (Beardslee, Versage, & Gladstone, 1998; Hammen, 1991; Orvaschel et al., 1988; Puig-Antich et al., 1985a, 1985b). Psychosocially, depressed parents tend to be withdrawn and fatigued or else irritable and critical (Cohn, Matias, Tronick, Donnell, & Lyons-Ruth, 1986; Field, Healy, Goldstein, & Guthertz, 1990). The extent to which such parental behaviors predict later child outcomes depends both on the severity of parental depression (Campbell, Cohn, & Meyers, 1995) as well as the child’s problem history and developmental stage (Chess & Thomas, 1984; Wickramaratne, & Weissman, 1998). During infancy, high-risk cohorts show less visual and vocal reciprocity with severely withdrawn-unresponsive caregivers, and they often display distress with intrusive-hostile caregivers (Cohn et al., 1986; Murray, Kempton, Woolgar, & Hooper, 1993; Shaw & Vondra, 1995; Zlochower & Cohn, 1996). During preschool years, depressed parent-child interactions tend to be brief and interrupted (Jameson, Gelfand, Kulcsar, & Teti, 1997), and discipline problems may increase out-of-control or aggressive behaviors (Zahn-Waxler, Iannotti, Cummings, & Denham, 1990). Parents may struggle to teach effective coping strategies to their school-aged children (Garber & Dodge, 1991; Gottman, 1997; Hillsman & Garber, 1995), and children may mirror their parents’ tearfulness and pessimism (Graham & Easterbrooks, 2000). During adolescence, high-risk family relationships tend to be marked by conflict, control, rejection, and guilt (Garber, Keiley, & Martin, 2002; Goldstein, 1995; Schwartz, Dorer, Beardslee, Lavori, & Keller, 1990; Sheeber & Sorensen, 1998). During teen years, family discord and emotional patterns predict the onset of depressive episodes in high-risk youngsters (Garber et al., 1999). Such observations suggest a developmental progression of early emotion discord and dysregulation, culminating in depressive disorders in some high-risk youngsters. The empirically supported principle of dynamic developmental trajectories creates a particularly strong rationale for multidisciplinary, longitudinal studies. Cross-sectional studies of isolated component processes often cannot capture this inherent feature of early-onset mood disorders.

Psychological Context

Empirical studies have demonstrated that during a depressive episode, youngsters have characteristic patterns of affect, behavior, cognition, and interpersonal style. Methodologies differ across studies, but replicated effects suggest convergent patterns that establish basic principles for a multi-disciplinary conceptualization of early-onset depression. For example, a number of studies support the notion that depressed teens have difficulties with emotion regulation strategies and behaviors such as support seeking, cognitive reappraisal, and affect change (Garber, Braafladt, & Weiss, 1995), and they are also likely to sustain their negative emotions longer than non-depressed teens (Sheeber, Allen, Davis, & Sorensen, 2000). Socially, hostility is common in boys, whereas conflict avoidance is common in girls (Davis, Sheeber, Hops, & Tildesley, 2000; Garber et al., 1995). In addition, depressed youngsters often selectively attend to negative emotions and events, and they frequently expect aversive outcomes to continue in the future (McCauley, Mitchell, Burke, & Moss, 1988; Kendall, Stark, & Adam, 1990).

Emotion regulatory problems are further supported by reports that many depressed youngsters are self-focused and ruminative about their feelings and shortcomings, and such self-focus tends to disrupt active task engagement and environmental exploration (Nolen-Hoeksema, 1991). Depressed youths commonly give low ratings of their academic and social competence, which may or may not reflect actual performance (Cole, Jacquez, & Maschman, 2001). When asked about the causes of negative events, depressed youngsters frequently make attributions that are self-blaming and catastrophic (Curry & Craighead, 1990; Gladstone, Kaslow, Seeley, & Lewinsohn, 1997; Kaslow, Rehm, Pollack, & Siegel, 1998; Nolen-Hoeksema, Girgus, & Seligman, 1986). Given that negative or biased cognitive patterns appear to escalate dysphoric mood and maintain depressive symptoms over time (Harrington & Vostanis, 1995), it is not surprising that depressed youths report greater daily sadness, fear, anger, and irritability than their peers (Altmann & Gotlib, 1988; Larson, Raffaelli, Richards, Ham, & Jewell, 1990; Quiggle, Garber, Panak, & Dodge, 1992). They appear to perseverate in a prolonged pattern of negative emotions in that they tend to continue or repeat dysfunctional emotional behaviors even after the cessation of emotionally provocative events.

Prior to the initial onset of an affective disorder, stress and regulatory factors increase risk of developing depression. Research links such life events primarily to the onset of an initial major depressive episode early in life (Lewinsohn, Allen, Seeley, & Gotlib, 1999). For example, serious illness or injury with functional impairment is a risk factor for an initial depressive episode in youngsters (Lewinsohn, Seeley, Hibbard, Rohde, & Sack, 1996). In addition, relationship loss is documented as a prospective risk factor for the first onset, but not recurrent episodes, of major depressive disorder (Monroe, Rohde, Seeley, & Lewinsohn, 1999). Witnessing family violence also predicts major depressive episodes (Daley, Hammen, & Rao, 2000). High risk for depression and suicide exists following physical or sexual abuse, with an eight-fold increase relative to controls (Brent et al., 1998, 1999; Brown, Cohn, Johnson, & Smailes, 1999; Kaplan et al., 1998; Kaufman, 1991; Kazdin, Moser, Colbus, & Bell, 1985; Roosa, Reinholtz, & Angelini, 1999). Such stressful life events may lead to prolonged emotional arousal that a youngster cannot control or regulate, which over time can become maladaptive and develop into an emotional disorder.

Although most youngsters are able to regulate their emotional arousal to stressful events with cognitive, behavioral, or social strategies, some are unable to adapt effectively. Existing data suggest that those who fail to regulate their arousal adaptively and develop depression may have a lower threshold for dealing with stress. In particular, longitudinal data from over 1500 community adolescents suggest that among those who experience stressful life events, depression occurs primarily in those who display highly dysfunctional cognitive-emotional patterns (Lewinsohn, Joiner, & Rohde, 2001). Other studies show that when youngsters become depressed, their cognitive patterns deteriorate and remain dysfunctional even after their depression subsides, putting them at risk for future episodes of depression (Nolen-Hoeksema et al., 1992). In community samples, dysphoric mood and dysfunctional thinking styles are more highly correlated among adolescents with a previous history of depression than among adolescents without a depression history, and dysfunctional thinking is a stronger predictor of recurrent depression than the first episode (Lewinsohn et al., 1999; Nolen-Hoeksema, Girgus, & Seligman, 1986, 1992). Findings support different interactions between stress and regulatory patterns in first onset depression relative to recurrent depression. Once youngsters develop dysregulated cognitive patterns, they may have reduced thresholds for high emotional arousal and depressive symptoms. Taken together, convergent evidence demonstrates that dysregulated or maladaptive affect is a core aspect of depression. Furthermore, problems with emotion adaptation appear to precede the onset of the disorder, and such difficulties increase risk for protracted symptoms and functional impairments necessary for a clinical diagnosis.

Intervention

Intervention research has identified empirically supported prevention and treatment programs for early-onset depression. Empirically supported interventions are those with beneficial effects shown in two or more independent, randomized clinical trials for a particular population (American Psychological Association Task Force, 1995; Chambless & Hollon, 1998; Hollon et al., 2002; Kazdin & Weisz, 1998). The current literature includes few meta-analyses, but a number of published empirical studies using standardized diagnostic criteria have systematically evaluated interventions for early-onset depression. Such systematic, controlled studies exemplify core findings and issues relevant for a broader multi-disciplinary discussion.

Prevention

In recent years, tools and incentives have become available for systematically evaluating primary prevention programs for depression (Brent, 2004; Harrington & Clark, 1998; Rutter, 1995). Primary prevention interventions typically target risk factors for depressive disorders, in a similar way that lung cancer prevention targets smoking behaviors. The current review focuses on primary prevention programs that specifically address depression in youngsters. The major empirically evaluated primary prevention programs include educational, cognitive-behavioral, family-focused, and combined cognitive-behavioral-interpersonal approaches.

Early studies documented that lecturing to large, unselected groups of youngsters about depression prevention had minimal effects on symptom reduction, depression knowledge, treatment attitudes, and treatment seeking (Clarke, Hawkins, Murphy, & Sheeber, 1993). However, benefits have been observed with more focused and intensive selective prevention programs, targeting only youngsters with elevated depressive symptoms. For example, Clarke and his colleagues adapted the program content from Lewinsohn and Clarke’s Coping with Depression Course for Adolescents (CWD-A), a cognitive-behavioral program used in treatment outcome research (see Clarke, 1999; Clarke & Lewinsohn, 1989; Lewinsohn, Clarke, & Hoberman, 1989). The 15-session, small-group prevention program teaches youngsters skills for identifying and challenging negative or biased thoughts that may lead to depression (i.e., mood monitoring, social skills, activity scheduling, relaxation, constructive thinking, communication techniques, problem solving, and maintenance strategies). Randomized clinical trials with high-risk adolescents showed significant benefits of prevention by substantially reducing cases of major depression and dysthymia during the follow-up period (Clarke et al., 1995, 2001).

A second research group also tested a 12-week cognitive-behavioral depression prevention program in school-aged youngsters, called the “Penn Resiliency Program”, based on the helplessness model of depression (Freres, Gillham, Reivich, & Shatte, 2002; Seligman, Reivich, Jaycox, & Gillham, 1995). The model draws analogies between depression in humans and passivity in lab animals in uncontrollable, aversive situations (see Peterson, Maier, & Seligman, 1993). Human helplessness is predicted by explanatory styles, or habitual “optimistic” or “pessimistic” causal explanations of aversive events. Key features of explanatory style are the degree of personalization (i.e., internal vs. external), permanence (i.e., stable vs. unstable), and pervasiveness (i.e., global vs. specific). The program promotes optimistic explanatory style, personal control, and mastery experiences using cognitive-behavioral techniques and social skills training. Controlled outcome studies showed that the prevention program reduced self-reported depressive symptoms, and follow-up studies documented continued depressive symptom reduction, improved classroom behavior, and more optimistic explanatory styles (Gillham & Reivich, 1999; Gillham, Reivich, Jaycox, & Seligman, 1995; Jaycox, Reivich, Gillham, & Seligman, 1994; Seligman et al., 1995).

Using a family-focused approach, Beardslee and his associates developed a 6-to-10-session program for high-risk youths with a depressed parent (Beardslee, Gladstone, Wright, & Cooper, 2003; Gladstone & Beardslee, 2000). Based on their work on resilience and self-understanding, the researchers designed the intervention to enhance understanding of depression in families and to decrease the impact of risk factors in youths (Beardslee, 1989; Beardslee & Poderefsky, 1988). Controlled studies documented that the intervention was associated with high parental satisfaction, overall symptom changes, improved communication, and interpersonal understanding (Beardslee, Salt, et al., 1997; Beardslee, Versage, et al., 1997). Follow-up studies documented sustained positive behavior and attitude changes. Change was related to a process that demystified depression, modulated shame and guilt, and increased self-awareness (Beardslee, Swatling, et al., 1998). A healthy family dialog promoted resilience among children (Focht & Beardslee, 1996).

Additional studies have combined cognitive-behavioral and interpersonal approaches in depression prevention. For example, Shochet and associates (2001) developed and evaluated a school-based program with an unselected group of 260 youngsters in Australia. Their active intervention program emphasized rapport and included both cognitive-behavioral and family-interpersonal techniques (e.g., calming skills, cognitive patterns, problem solving, support networks, family interactions). The investigators documented a high recruitment rate, low attrition rate, and satisfactory protocol adherence. The program resulted in reduced depressive symptoms in the 20 percent of adolescents with elevated symptomatology, whereas, clinical depression increased markedly in a control group that did not participate in the program. Beneficial effects were sustained at the 10-month follow-up assessment.

In general, research shows that promising depression prevention programs: (1) build specific cognitive and behavioral skills as protective factors, (2) help children and families improve emotional awareness and regulation, and (3) improve relationships of children and parents (Surgeon General, 2001). Large-group universal prevention strategies can have potentially harmful effects (Harrington & Clark, 1998). Small-group programs that actively relate skill-building to personal experience appear more effective than large-group lecture programs.

Treatment

Controlled treatment trials with acutely depressed children and adolescents who meet diagnostic criteria for major depression or dysthymia mainly focus on brief psychological or pharmacological interventions (see Birmaher, Ryan et al., 1996a, b; Birmaher, Brent, & Benson, 1998; Harrington, Whittaker, & Shoebridge, 1998; Hughes et al., 1999; Kovacs & Sherrill, 2001; Martin, Kaufman, & Charney, 2000). The following review summarizes published randomized clinical trials with youngsters between ages 6 to 18 years who met operational diagnostic criteria for major depression or dysthymic disorder based on the DSMIII, DSMIII-R, or DSMIV or who were diagnosed with Research Diagnostic Criteria (RDC) for major, intermittent, or minor depressive disorder. Diagnoses were determined through standardized, structured, or semi-structured psychiatric interviews. Meaningful comparisons across study studies were complicated by differences in design and outcome measures. To address this, summary statistics reported here were computed by noting the number of participants who entered each clinical trial and the number of youngsters who remitted from depression at the end of the acute treatment phase. By considering all eligible participants for computing response rates, the summary reflects an intent-to-treat approach described by Pocock (1983). General comparisons were then made within and across major pharmacological and psychological treatment modalities and trends were identified for further discussion.

Psychological Treatments

Various versions of cognitive-behavioral therapy have been the most widely studied type of non-somatic intervention for depressed youths (Harrington, Whittaker, & Shoebridge, 1998; Hibbs & Jensen, 1996; Kovacs & Sherrill, 2001). Cognitive-behavioral treatments, which represent adaptations from interventions originally designed for adults, generally seek to help youths identify and modify negative thoughts, dysfunctional beliefs, and pessimistic attributions as well as to build more adaptive behavioral, communication, and problem solving repertoires. Randomized clinical trials with standardized outcome measures for acute depression compared cognitive-behavioral therapy with control interventions, including family therapy, non-directive supportive therapy, and waiting lists (see Brent et al., 1997; Harrington, Kerfoot, et al., 1998; Lewinsohn, Clarke, Hops, & Andrews, 1990; Lewinsohn, Clarke, Rohde, Hops, & Seeley, 1996; Vostanis, Feehan, Grattan, & Bickerton, 1996; Wood, Harrington, & Moore, 1996). In general, half to three-fourths of depressed youngsters remitted from depression with cognitive-behavioral therapy, a somewhat lower percentage remitted with nondirective supportive therapy, and 5 to 50 percent remitted on waiting lists. A high recovery rate of 75 percent has also been reported for interpersonal therapy (Mufson, Weissman, Moreau, & Garfinkel, 1999).

Medication Treatments

Pharmacological treatments for depression target chemical dysfunction in the nervous system, and medication use for depressed youngsters has increased markedly during the past decade (Ryan, 2003a, b; Surgeon General, 1999). Some of the earliest empirical studies focused on tricyclic antidepressants, which primarily affect norepinephrine and serotonin systems (see Birmaher, Waterman, et al., 1998, amitriptyline; Boulos et al., 1991, desipramine; Geller et al., 1989,1990, nortriptyline; Hughes et al., 1990, imipramine; Klein et al., 1998, desipramine; Kutcher et al., 1994, desipramine; Kye et al., 1996, amitriptyline; Puig-Antich et al., 1987, imipramine). Individual studies as well as a meta-analysis reported no significant outcome differences between youngsters assigned to tricyclic treatment or a placebo medication (Hazell et al., 1995). In general, such studies show minimal efficacy for tricyclics, and they document risk for cardiotoxicity in pediatric populations (Gutgesell et al., 1999; Werry et al., 1995).

Additional pharmacologic research has focused on the serotonin reuptake inhibitors (SRIs), given their improved safety profile relative to the tricyclics. Published reports have focused primarily on fluoxetine (i.e., Prozac), paroxetine (i.e., Paxil), or sertraline (i.e., Zoloft). In randomized controlled studies, over half of depressed youngsters treated with fluoxetine were rated “much” or “very much improved” on the Clinical Global Impression Scale, and approximately one-third remitted from depression (Emslie et al., 1997). When given paroxetine, almost two-thirds of depressed youngsters remitted from their depression, with slightly better clinical outcomes than depressed youngsters in the placebo control condition (Keller et al., 2001). In addition, almost 70 percent of youngsters with major depressive disorder who were given sertraline showed substantial decreases in depressive symptoms in pooled multicenter, randomized, double-blind, placebo-controlled trials (Wagner et al., 2003). Response rates above 70 percent have been observed with combined fluoxetine and cognitive-behavioral therapy in adolescents with major depressive disorder (March et al., 2004). Collective evidence underscores the need to balance risk-benefit ratios for SRI use in youngsters, and a meta-analysis of both published and unpublished data indicates that only fluoxetine has a favorable risk-benefit profile among medications for treating depressed youngsters (Whittington et al., 2004).

Taken together, research shows that two-thirds to three-fourths of depressed youngsters show symptomatic improvement with acute treatment. However, not all treatments are equally effective. The most consistently replicated benefits occur when youngsters learn various cognitive and behavioral techniques for coping with their depression, and such effects show continuity with established cognitive-behavioral depression prevention programs. In addition, when medications are needed, treatment benefits improve with combined SRI and psychotherapy. Serious side effects have been clearly documented with the tricyclic antidepressants. Evidence that tricyclic treatment is not effective for depressed youngsters contrasts with positive effects for adults. These findings underscore the limitations of generalizing results from treatment studies with depressed adults to children and adolescents (Kaufman et al., 2001). Depressed children and adolescents need interventions optimized for their unique needs (Coyle et al., 2003; Shonkoff, 2003).

Neurobiology

Neurobiological studies with depressed children and adolescents have primarily used neuroendocrine, electrophysiological, and neuroimaging techniques. Such measures have been assessed during resting baseline and challenge conditions. In addition, researchers have used cross-sectional research designs to identify neurobiological correlates of the acute disorder, and they have developed longitudinal research designs to study factors that precede illness onset and predict risk status over time. Such studies are not without methodological limitations, but convergent patterns across studies allude to important principles that can inform both applied clinical work and ongoing basic research. Perhaps most fundamentally, such studies suggest that multiple neurobiological factors contribute to one’s capacity for adaptive emotional responses, which become dysfunctional in depressive illness.

Neuroendocrinology

Neuroendocrine studies have documented neurochemical dysregulation in depressed youngsters, which changes across development. Although depressed adults show marked abnormalities in 24-hour baseline cortisol patterns (Gold, Goodwin, & Chorousos, 1988a, 1988b; Post, 1992), studies with prepubertal depressed children suggest that such children do not tend to display such stress hormone dysregulation (Feder et al., 2004; Puig-Antich, 1986a, 1986b; Puig-Antich, Dahl, et al., 1989). Resting cortisol dysregulation in depression appears to emerge after puberty, specifically in the evening hours and during sleep disturbance (Dahl et al., 1991; Dahl et al., 1992; Kupfer, 1993). Such replicated observations establish that abnormal 24-hour baseline cortisol patterns may be a consequence, rather than a cause, of depressive disorder.

A longitudinal study of depressed adolescents followed into adulthood showed a relation between significant pre-sleep cortisol elevations and later suicide attempts (Mathew et al., 2003). Researchers observed that depressed adolescents often have reduced growth hormone before sleep onset, and those who are suicidal tend to display rapid increases after sleep onset (Coplan et al., 2000). Disrupted sleep processes during a depressive episode may increase subsequent biological and psychological dysregulation (Dahl, 1998; Dahl et al., 1996; Steiger & Holsboer, 1997a, 1997b). Thus, even though sleep-related cortisol changes may be a consequence of a depressive disorder, such processes contribute fundamentally to ongoing and escalating problems with regulating stress responses.

In addition to the baseline cortisol studies, a number of neuroendocrine challenge studies have been conducted. In general, pubertal status affects girls’ and boys’ responses differently. Healthy girls show increasing CRH-related cortisol responses with pubertal development, but boys have similar total responses across pubertal stages (Stroud et al., 2004). Prepubertal girls, but not boys, with depressive disorders display augmented prolactin responses to serotonin-related drug challenges relative to healthy comparison participants (Ryan et al., 1992). Some effects are present in both girls and boys. In particular, prepubertal depressed girls and boys who are given serotonin-related drug challenges produce blunted cortisol responses (Ryan et al., 1992) as well as blunted pituitary growth hormone responses (Ryan et al., 1994). Such cortisol and growth hormone responses to serotonin-related challenges have also been observed in non-depressed high-risk children with a strong family loading for severe depression (Birmaher et al., 1997). In addition, blunted growth hormone responses after insulin-induced hypoglycemia exist both after remission in depressed youngsters (Ryan et al., 1994) and prior to an initial episode in high-risk children with a family history of severe depression (Birmaher et al., 2000; Dahl et al., 2000). Such longitudinal evidence suggests that dysregulated growth hormone patterns may have a causal role in depression, particularly among some youths with a family history of mood disorder.

Electroencephalography

Baseline physiological studies of electroencephalographic (EEG) alpha suppression have been conduced with multiple populations. Adolescents with major depressive disorder tend to have decreased left frontal and right parietal brain electrical activity, two of the brain areas that are implicated in emotional expression and perception, respectively (Kentgen et al., 2000; Tomarken & Keener-Miller, 1998). However, parietal asymmetry was reduced in the presence of comorbid anxiety (Kentgen et al., 2000). In high-risk youngsters of depressed mothers, investigators have documented left hypoactivation and atypical frontal brain electrical activity relative to low-risk children (Dawson et al. 1997a, 1997b, 1999a, 1999b; Field, Fox, Pickens, & Nawrocki, 1995; Tomarken & Keener-Miller, 1998; Tomarken, Dichter, Garber, & Simien, 2004). In a study of young adults with a history of familial childhood-onset depression, investigators found that frontal EEG alpha asymmetry differed between men and women and varied in relation to longitudinal clinical course (Miller et al., 2002). Women showed greater alpha power at all sites than men, and young women with childhood-onset depression had greater right frontal alpha suppression while men with childhood depression had greater left frontal alpha suppression. Participants with a bipolar spectrum course had the most extreme patterns of frontal EEG asymmetry. This study illustrates the principle that clinical variability accounts for important variance in electroencephalographic studies of familial, early-onset depression.

EEG sleep measures have shown considerable variability with regard to group differences between depressed youngsters and control participants. Such measures are influenced substantially by age and gender (Armitage et al., 2000), and depression-related effects appear to interact with medication effects and longitudinal clinical course. Armitage, Emslie, and Rintelmann (1997) observed that fluoxetine (Prozac) treatment in depressed children and adolescents increases subjective sleep disturbance, light Stage 1 sleep, number of arousals, myoclonic activity, and rapid eye movement (REM) density. However, REM latency was largely unaffected. In a longitudinal follow-up study, EEG sleep measures differed among depressed adolescents with a unipolar or bipolar course (Rao et al., 2002). A unipolar course was associated with reduced REM latency, higher REM density, and increased early REM sleep. A bipolar course was related to more Stage 1 sleep and less Stage 4 sleep. In a study assessing the temporal coherence of EEG rhythms during sleep (Armitage et al., 2000), both depressed children and adolescents had lower intrahemispheric coherence than healthy controls, suggesting a disruption in basic brain arousal and organization. In addition, coherence between the two cerebral hemispheres was reduced among depressed adolescents (but not children), with the lowest interhemispheric coherence observed among depressed adolescent girls.

Neuroimaging

Neuroimaging studies have also been done with depressed adolescents. Such studies are marked by small sample sizes and inconsistent findings. One set of studies has focused on frontal cortex abnormalities. For example, Steingard et al. (1996) reported reduced frontal lobe volumes in depressed adolescents, and later documented smaller frontal white matter volumes, but larger frontal gray matter volumes, in depressed adolescents compared to healthy controls (Steingard et al., 2002, 2000). Nolan et al. (2002) studied psychotropically-naive 9 to 17 year old youngsters with major depressive disorder and found that frontal volumes differed among those with or without a family history of affective illness. Those adolescents with familial depression had left frontal volumes that were 6 percent smaller than healthy comparison participants, but adolescents with non-familial major depressive disorder had left frontal volumes that were 11 percent larger than the comparison group. Such findings underscore the basic principle that the familial patterns are essential for understanding the nature of early-onset depression.

Another set of studies focused specifically on medial prefrontal areas. For example, Botteron and her associates (2002) reported volume reductions specifically in the left orbitofrontal cortex (i.e., medial subgenual cingulate) in depressed adolescents. The left subgenual cortex of the depressed adolescents was on average 19 percent smaller than control participants. This work extends prior findings that adults with familial-pure unipolar or bipolar depression have abnormal left medial frontal glucose metabolism, structural volume reduction, and glial cell reduction. Such effects may possibly reflect developmental abnormalities in medial frontal and related areas that modulate autonomic and neuroendocrine stress responses and reward sensitivity (Drevets, 2000; Rajkowska et al., 1999). Questions remain about why some investigators have been unable to replicate subgenual cortex volumetric effects in independent samples (e.g., Sanches et al., 2005).

Another set of studies has focused on the amygdala, hippocampus, striatum, and temporal cortex using both structural and functional neuroimaging. In these studies, depression-related effects appear to be moderated by the presence of anxious and/or manic symptoms. For example, MacMillan et al. (2003) found that medication-free children and adolescents with major depressive disorder had 14 percent larger left and 11 percent larger right amygdala-hippocampal volume ratios than comparison participants. However, such volume differences were directly related to the severity of anxiety symptoms, but not depressive symptoms nor illness duration. Rosso et al. (2005) reported reduced bilateral amygdala volumes in pediatric major depression, but effects were unrelated to symptom severity. Thomas et al. (2001) used functional magnetic resonance imaging with an emotional face task to study children and adolescents with major depressive disorder, generalized anxiety or panic disorder, or no psychiatric history. Youths with anxiety disorders showed an exaggerated amygdala response to fearful faces relative to comparison participants, whereas youths with major depression showed a blunted amygdala response to the faces. The magnitude of the amygdala's signal change between fearful and neutral faces was positively correlated with the anxious symptom severity.

In a study of adolescents with bipolar disorder and healthy controls, investigators documented reduced left total superior temporal gyrus volumes in the bipolar group, and the effect was related to differences in bilateral white matter volume (Chen et al., 2004a). Researchers also showed that amygdala volume was positively correlated with age among adolescents with bipolar disorder but negatively correlated with age among healthy comparison participants (Chen et al., 2004b). Dickstein et al. (2005) examined children with bipolar disorder and documented reduced gray matter volume in the left dorsolateral prefrontal cortex, accumbens, and amygdala. Focusing specifically on subcortical temporal structures, Blumberg et al. (2003a) reported a significant 15.6 percent amygdala volume reduction and a marginal 5.3 percent hippocampal volume reduction in adolescents and young adults with bipolar disorder relative to healthy control participants. However, such volume effects appeared unrelated to bipolar illness duration, mood state, rapid cycling, medication, or substance dependence. These researchers also assessed adolescents with bipolar disorder or no psychiatric history using event-related functional magnetic resonance imaging during a color-naming Stroop task (Blumberg et al., 2003b). Relative to healthy adolescents, those with bipolar disorder had greater left striatal and thalamic activity as well as an absence of age-related prefrontal activity. Within the bipolar group, signal increases in the ventral striatum correlated positively with depressive symptoms. The results suggest developmental dysfunction in subcortical frontostriatal brain regions in adolescents with bipolar disorder (Blumberg et al., 2004).

Summary of Neurobiological Research

Neuroendocrine, electrophysiological, and neuroimaging research suggests that child and adolescent depression emerges from dysfunction in neural systems involved in emotion. Neurobiological factors change during the course of development (DeBellis et al., 2001), and developmentally-influenced neurobiological factors appear to contribute to one’s capacities for adaptive emotional responses. The limited available evidence to date suggests that emotion-related neurobiological processes that change with development may become impaired during depressive disorders. Longitudinal developmental studies that account for familial and clinical variability allude to this possibility, and cross-sectional studies that fail to account for developmental changes, gender differences, and family history have produced inconsistent results.

As reviewed above, currently depressed prepubertal children, previously depressed children, and non-depressed high-risk children show blunted cortisol and growth hormone responses to serotonin-related drug challenge or insulin-induced hypoglycemia. Neuroendocrine findings underscore the importance of basic biological rhythms involved in sleep, eating, and stress sensitivity. Differences between depressed and non-depressed youngsters have been identified in the structure and function of cortical, limbic, and striatal brain areas. Much remains to be learned about how observed human brain activity relates to particular functional components of mood disorders, but basic research with laboratory animals suggests that the prefrontal cortex and related cortical-limbic-striatal circuits regulate emotional functions such as neuroendocrine stress responses, autonomic reactivity, and reward sensitivity (Ongur & Price, 2000).

An important direction for future neurobiological research is to translate findings across different levels of analysis. For example, as stated above, early-onset mood disorders have been associated with BDNF gene polymorphisms, blunted peripheral cortisol and growth hormone responses, as well as prefrontal and cortical-limbic-striatal brain circuit changes. Future inquiries should identify relations among such molecular, chemical, and functional neurobiological processes and address questions about gender and developmental influences. In addition, much remains to be learned about how such processes relate to the complex treatment responses and clinical presentations of depressed youngsters. As such interactions become understood, the science will increasingly inform better matching between symptoms and treatments. Yet, the compelling challenge of matching symptoms and treatments is complicated by emerging data. Neurobiological factors in early-onset mood disorders may fundamentally involve variations in dynamic developmental brain mechanisms that are formed through interactions with the environment. Rather than correcting focal deficits, the key challenge may be finding ways to intervene in dynamic biological processes that are inherently shaped by the environment.

A Social Neuroscience Perspective

Translational research aims to integrate our understanding of interventions, neurobiology, psychopathology, and normal development. Such efforts depend fundamentally on both basic and clinical science. The scientific literature about child and adolescent depression provides a substantial empirical foundation for beginning to develop an integrative research framework that has implications for both typical and atypical development.

In this context, developmental social neuroscience offers a useful perspective. The goal is neither to reduce child and adolescent depression to isolated neurobiological measures nor to give broad generalizations with metaphorical terminology. Rather, this dynamic system perspective seeks to understand developmental variations in specific brain processes that are shaped by environmental inputs. The framework embraces the multi-disciplinary goal of programmatically developing, testing, and refining theories of early-onset depression that bring together the elaborate details of neuroscience with the multifaceted context of early emotional experience. Important tasks at hand are (1) to characterize core features of emotional processes and disorders, (2) to differentiate component processes of complex emotional function and dysfunction, (3) to identify relations among such component processes and their contextual influences, and (4) to elaborate the developmental changes inherent in the early emergence of depressive disorders. Such tasks serve the goal of identifying the mechanisms of how the initial-onset of depression occurs in different individuals and how it can be prevented.

Analyzing component parts of typical and atypical emotional processes must proceed in concert with a vision for a unified gestalt, and so another important scientific challenge is developing a heuristic for generating hypotheses about etiology and guiding interventions for early-onset mood disorders. Growing evidence suggests that emotional adaptation should be at the core of such a heuristic (Shelton, 2000). Emotional adaptation is a fundamental process that enables the brain to receive and integrate environmental and somatic information and to guide appropriate responses over time. It can be examined at multiple levels of analysis. For example, cellular mechanisms contribute to emotional adaptation, synaptic plasticity, and depressive disorders (Durman, 2002; Shelton, 2000; Tsai, 2005). Emotional adaptation is also essential to research about brain reward circuits (Leibenluft, Charney, & Pine, 2003; Ongur & Price, 2000) and neuroendocrine systems (Romeo, 2005; Sisk & Foster, 2004). In addition, emotional regulatory processes are being examined across physiological, behavioral, cognitive, and social domains (Calkins & Fox, 2002). An emotional adaptation heuristic serves the goal of seeking convergent, replicable observations made from different viewpoints and with different methodologies.

A Dynamic Adaptive Systems Framework

The central guiding hypothesis of the dynamic adaptive systems framework is that mood disorders reflect core deficits in emotional adaptation, and facilitating emotional adaptation provides a pathway to resilience. This framework begins by juxtaposing two fundamental principles from the adult depression literature. First, Charney and his colleagues (2002) emphasize parsing mood disorders into core features that are clinically meaningful and quantitatively assessable. Second, Shelton (2000) uses emotional adaptation as an explanatory heuristic for investigating the mechanisms of risk for depression and response to treatment. These perspectives exemplify ways to investigate complex interacting systems that change dynamically over time. They provide a structure for integrating observations reviewed in this paper and for generating multiple working hypotheses for studying early-onset depression and emotional resilience (Chamberlin, 1965).

Studying nosology teaches us that depressive disorders comprise disparate symptoms, with disturbance of mood, sleep, eating, motor behavior, thought, and self-esteem (Charney et al., 2002). The symptoms collectively indicate a coherent syndrome. However, they do not occur in the same distribution in every depressed person. In addition, early-onset depression is marked by inherent patterns of overlap among symptoms of other internalizing and externalizing disorders. In order to examine the core components, dimensions, and categorical boundaries of depression, several investigators have conducted factor analytic studies of mood-related symptoms in children (Lahey et al., 2004) and adults (Brown, DeNardo, Lehman, & Campbell, 2001; Gullion & Rush, 1998; Korszun et al., 2004; Nelson & Charney, 1981). The general factor structure emerging from such work informs investigations of how diverse psychological, biological, and clinical observations may converge and diverge.

Hedonic Capacity

One of the most consistent observation among factor analytic studies of depression is that substantial unique variance in symptomatology is accounted for by a decreased hedonic capacity factor, characterized by items such as sad mood, anhedonia, loss of interest, lack of pleasure and enjoyment, decreased energy, fatigability, daytime sleepiness, psychomotor retardation, and walking or talking slower. As Hasler, Drevets, Manji, and Charney (2004) have noted, anhedonia has trait-like characteristics (Farmer et al., 2003). In addition, it is relatively specific to the depressive syndrome (Fawcett et al., 1983; Loas et al., 1999), often prodromal to major depression (Dryman & Eaton, 1991), and relatively stable over time (Oquendo et al., 2004).

A hedonic capacity construct has biological significance due to relations with brain reward systems and adaptive processes. Variations in reward sensitivity have been linked to the prefrontal cortex and related brain circuits (Kringelbach & Rolls, 2004; Rolls, 2004; Price, Carmichael, & Drevets, 1996) as well as dopaminergic and serotonergic neuromodulation in such brain circuits (Miner, Schroeter, Blakely, & Sesack, 2000; Sasaki-Adams & Kelley, 2001; Tremblay et al., 2002). In addition, both neurotransmitters and neurotrophic factors mediate long-term alterations of the brain reward system and enable adaptive emotional responses (Nestler et al., 2001, 2002). A large body of basic research has examined the brain reward system at multiple levels of analysis.

The current adaptive systems framework suggests that early-onset depression may be characterized by deficits in hedonic capacity and dysregulation of the brain reward system. This hypothesis would be supported by neurobiological evidence that youngsters with early-onset mood disorders have prefrontal and limbic abnormalities marked by disrupted brain development. This hypothesis also relates to molecular genetic evidence implicating neurotrophin gene variants in childhood-onset mood disorders. Such genetic polymorphisms may fundamentally alter brain development and adaptive processes. In addition, the mechanisms of reward-related prefrontal neurotransmitter and neurotrophic processes have implications for understanding the efficacy of antidepressant drugs and how such processes may change during development. Furthermore, promoting healthy mastery and reward-related behaviors, such as regular aerobic exercise, may be an important component of treating and preventing depression.

Stress Sensitivity

A second fundamental component of depressive symptomatology is increased stress sensitivity, marked by dysfunction following major life events, sympathetic arousal, somatic anxiety, gastrointestinal symptoms, headaches, agitation, and irritability. Stress sensitivity also can be related to dysregulated sleep and eating. Debate exists about potential overlaps in stress-related symptoms among depressive and anxiety disorders. Data are converging and suggest that depression shares considerable variance with generalized anxiety disorder but less with other anxiety disorders such as phobias (Lahey et al., 2004). Notably, the stress-related component of depressive symptoms may be influenced by age and gender. For example, a factor analytic study of symptoms reported by third graders, their parents, and their teachers supported a single dimension of anxiety and depression, but separate anxiety and depression dimensions emerged when the children reached the sixth grade (Cole, Truglio, & Peeke, 1997). Such evidence raises the possibility that stress-related depressive symptoms may change in critical ways with pubertal development.

Considerable basic research has examined stress sensitivity in relation to neuroendocrine and autonomic systems. In addition, basic studies reveal the exquisite details of neuroendocrine processes involved in puberty (Sisk & Foster, 2004). Pubertal hormones fundamentally influence not only male and female genitalia. Hormonal changes also alter hypothalamic and related brain areas that regulate the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic nervous system. When people experience prolonged and elevated stress, they may develop dysregulated biological and psychological feedback mechanisms. The cycle may reduce thresholds for triggering autonomic arousal and depressive symptoms.

The current adaptive systems framework suggests that early-onset depression may be characterized by increased stress sensitivity and dysregulated HPA and autonomic responses. Early aspects of this dynamic process may include blunted growth hormone responses that influence developmental processes. Cortisol and other stress-hormone dysregulation may come later in response to prolonged distress. In addition, gender differences may be a fundamental aspect of such processes. Previous studies document that males and females differ in the exposure rates and depressogenic effects of stressful life events (Kendler et al., 2001). Likewise, aforementioned biological studies of stress and 24-hour cortisol levels have revealed puberty- and gender-related effects, including the finding that post-pubertal females generally show greater neuroendocrine stress responses than men (Young, 1998) and that women and men display greater cortisol responses to social rejection and achievement challenges, respectively (Stroud et al., 2002). Findings in this area are important for pharmacologic and cognitive-behavioral interventions (see Jacobs, 2001; Sherrill & Kovacs, 2004). In addition, studies have implications for novel approaches for regulating stress such as social bonding and massage (see Field, 2002; Frank et al., 2000).

Ruminative Self-Focus

Third, factor analytic studies of depressive symptoms emphasize a ruminative self-focus factor, characterized by items such as negative emotional bias, self-dislike, worthlessness, self-criticism, self-blame, guilt, sense of failure, feeling punished, and interpersonal rejection sensitivity. Limited evidence exists for the stability and heritability of negative rumination, except that suicidal rumination and recurrent thoughts of death appear to be a specific characteristic of familial major depressive disorder (Kendler et al., 1999). Further studies are needed to investigate whether persistent ruminations about death, self-destruction, and self-injury mark a particularly serious form of familial mood disorders with high risks for acting on such thoughts. Questions also remain about the extent to which suicidal rumination is categorically distinct from or exists on a continuum with other aforementioned ruminative symptoms.

The current adaptive systems framework suggests that early-onset depression may be characterized by ruminative self-focus. Such patterns may emerge with growing capacities for abstract thought during typical development, and self-destructive ruminations may be particularly severe among youngsters with a family history of mood disorders. Psychological science and neuroscience studies of ruminative self-focus have much to offer a multidisciplinary social neuroscience research program (Tomarken & Keener-Miller, 1998). A guiding hypothesis is that depressed adolescents may perseverate in a prolonged pattern of negative emotions. They may continue or repeat dysfunctional emotional behaviors even after the cessation of emotionally provocative events, and they may display emotionally-impaired decision making. Notably, perseverative and maladaptive emotional behaviors characterize laboratory animals with experimentally induced prefrontal cortex lesions (Jacobsen, 1935; Nauta, 1971). The prefrontal cortex and related areas appear fundamental to both emotional dysfunction and adaptive resilience. Critical work remains with linking basic neuroscience observations about prefrontal and related brain circuits to the developmental emotional trajectory of depressed youngsters.

Ruminative self-focus has psychological and clinical relevance, because it is related to both cognitive-behavioral and interpersonal formulations of depressive disorder and intervention strategies. Highly elaborate intervention techniques are available for addressing maladaptive ruminative patterns. Developing healthy appraisal and attribution skills for examining beliefs and interpretations provides a powerful way to cope with stress. Factor analytic studies of child psychopathology may offer ways to extend such work (Lahey et al., 2004). Among children, rumination-related items loading on the depression factor were characterized by isolation and anger (e.g., wanting to be alone, anger at other people or things, and social hostility), and an independent factor represented social anxiety and fear (e.g., nervous in front of people, embarrassed, shy, lacking self-confidence, not feeling good looking or smart, and worried about mistakes). These observations clearly distinguish patterns related to anger and fear, and they allude to a potential developmental progression of social and egocentric cognitions, such that ruminative content may change as children develop greater self-other awareness and emotional affordances. If so, such developmental processes for learning to navigate one’s relationships with the environment and other people could be targeted to promote emotional resilience across the lifespan.

Attentional Impairments

Fourth, factor analytic studies of depressive symptoms have addressed general cognitive problems such as inattention, distractibility, and trouble concentrating. However, such studies generally have not identified a discrete depression-related factor. In a study of child psychopathology, an inattention factor emerged separately from hyperactivity/oppositional behavior, depression, conduct problems, and anxiety (Lahey et al., 2004). In general, difficulties with attention and concentration are included in DSM-IV diagnostic criteria for a major depressive episode, but such impairments are not specific for depression and tend not to be stable over the course of depressive illness (Oquendo et al., 2004). The current adaptive systems framework hypothesizes that attention-related symptoms are common during depressive and manic episodes, but that they may not reflect a specific, stable, causal mechanism of unipolar or bipolar depression. Despite the weak explanatory power of attention-related processes, such cognitive issues may be an essential part of treatment and prevention programs aimed at facilitating healthy development. For example, intervention and remediation focused on attention, learning, and memory may be an essential treatment component for youngsters with depression and other psychopathology in order to alleviate some of the consequences of the disorder, particularly when disorders are protracted or recurrent. Functional concomitants that can create confounds for etiologic studies may be among the most essential factors to address in general intervention programs to improve people’s lives. This may be especially important for depressed youngsters with comorbid attention deficit disorder or learning disabilities. In addition, suffering with depression during childhood or adolescence can interfere with achieving developmental milestones. Caring for such youngsters involves recognizing such potential delays and nurturing their optimal development.

Closing Remarks

In summary, the current paper reviewed a growing scientific literature about the psychopathology, intervention, and neurobiology of child and adolescent depression. A developmental social neuroscience perspective provides a theme for integrating disparate findings and spawning testable hypotheses about the relations among symptom presentation, biopsychosocial processes, and clinical interventions. An emerging principle is that early-onset depression may be related to developmental variations in neurobiological processes that are shaped by environmental inputs.

A dynamic adaptive systems framework is based on the guiding hypothesis that mood disorders may reflect core deficits in emotional adaptation, and facilitating emotional adaptation may provide a pathway to resilience. Emotional adaptation is a fundamental process that enables the brain to receive and integrate environmental and somatic information and to guide appropriate responses over time, and the construct can be examined from multiple levels of analysis. The adaptive systems framework addresses how the symptoms of depressive phenomenology can be parsed into empirically-derived terms of hedonic capacity, stress sensitivity, ruminative self-focus, and attentional impairments. Such components are clinically meaningful and quantitatively assessable and can be related to basic adaptive neurobiological, psychological, and developmental processes that are relevant to etiology and intervention. The dynamic adaptive systems framework suggests continuity between typical and atypical developmental processes, and it can be applied to study processes involved in depressive disorders as well as pathways to emotional resilience.

Author Note

I thank Dr. Maria Kovacs for her generous comments on an earlier draft of this manuscript. Support was provided by a NARSAD Young Investigator Award, the Educational Foundation of America, and NIMH Postdoctoral Fellowship MH18951.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Allen NB, Badcock PB. The social risk hypothesis of depressed mood: Evolutionary, psychosocial, and neurobiological perspectives. Psychological Bulletin. 2003;129:887–913. doi: 10.1037/0033-2909.129.6.887. [DOI] [PubMed] [Google Scholar]
  2. Altmann EO, Gotlib IH. The social behavior of depressed children: An observational study. Journal of Abnormal Child Psychology. 1988;16:29–44. doi: 10.1007/BF00910498. [DOI] [PubMed] [Google Scholar]
  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd Ed., 3rd Ed.-revised, 4th Ed. Washington, DC: American Psychiatric Association; 1980 1987 1994. [Google Scholar]
  4. American Psychological Association Task Force on Promotion and Dissemination of Psychological Procedures. Training in and dissemination of empirically-validated psychological treatments: Report and recommendations. Clinical Psychologist. 1995;48:3–23. [Google Scholar]
  5. Anderson JC, Williams S, McGee R, Silva PA. DSM-III disorders in preadolescent children. Archives of General Psychiatry. 1987;44:69–76. doi: 10.1001/archpsyc.1987.01800130081010. [DOI] [PubMed] [Google Scholar]
  6. Angold A, Costello EJ. Depressive comorbidity in children and adolescents: Empirical, theoretical, and methodological issues. American Journal of Psychiatry. 1993;150:1779–1791. doi: 10.1176/ajp.150.12.1779. [DOI] [PubMed] [Google Scholar]
  7. Armitage R, Emslie GJ, Hoffmann RF, Weinberg WA, Kowatch RA, Rintelmann J, Rush AJ. Ultradian rhythms and temporal coherence in sleep EEG in depressed children and adolescents. Biological Psychiatry. 2000;15:338–350. doi: 10.1016/s0006-3223(99)00129-8. [DOI] [PubMed] [Google Scholar]
  8. Armitage R, Emslie G, Rintelmann J. The effect of fluoxetine on sleep EEG in childhood depression: A preliminary report. Neuropsychopharmacology. 1997;17:241–245. doi: 10.1016/S0893-133X(97)00048-1. [DOI] [PubMed] [Google Scholar]
  9. Beardslee WR. The role of self-understanding in resilient individuals: The development of a perspective. American Journal of Orthopsychiatry. 1989;59:266–278. doi: 10.1111/j.1939-0025.1989.tb01659.x. [DOI] [PubMed] [Google Scholar]
  10. Beardslee WR, Gladstone TR, Wright EJ, Cooper AB. A family-based approach to the prevention of depressive symptoms in children at risk: Evidence of parental and child change. Pediatrics. 2003;112:119–131. doi: 10.1542/peds.112.2.e119. [DOI] [PubMed] [Google Scholar]
  11. Beardslee WR, Poderefsky D. Resilient adolescents whose parents have serious affective and other psychiatric disorders: Importance of self-understanding and relationships. American Journal of Psychiatry. 1988;145:63–69. doi: 10.1176/ajp.145.1.63. [DOI] [PubMed] [Google Scholar]
  12. Beardslee WR, Salt P, Versage EM, Gladstone TR, Wright EJ, Rothberg PC. Sustained change in parents receiving preventative interventions for families with depression. American Journal of Psychiatry. 1997;154:510–515. doi: 10.1176/ajp.154.4.510. [DOI] [PubMed] [Google Scholar]
  13. Beardslee WR, Swatling S, Hoke L, Rothberg PC, van de Velde P, Focht L, Podorefsky D. From cognitive information to shared meaning: Healing principles in prevention intervention. Psychiatry. 1998;61:112–129. doi: 10.1080/00332747.1998.11024822. [DOI] [PubMed] [Google Scholar]
  14. Beardslee WR, Versage EM, Gladstone TR. Children of affectively ill parents: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry. 1998;37:1134–1141. doi: 10.1097/00004583-199811000-00012. [DOI] [PubMed] [Google Scholar]
  15. Beardslee WR, Versage EM, Wright EJ, Salt P, Rothberg PC, Drezner K, Gladstone TR. Examination of preventative interventions for families with depression: Evidence of change. Development and Psychopathology. 1997;9:108–130. doi: 10.1017/s0954579497001090. [DOI] [PubMed] [Google Scholar]
  16. Birmaher B, Brent DA, Benson RS. Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. American Academy of Child and Adolescent Psychiatry. 1998;37:1234–1238. doi: 10.1097/00004583-199811000-00029. [DOI] [PubMed] [Google Scholar]
  17. Birmaher B, Dahl RE, Williamson DE, Perel JM, Brent DA, Axelson DA, Kaufman J, Dorn LD, Stuff S, Rao U, Ryan ND. Growth hormone secretion in children and adolescents at high risk for major depressive disorder. Archives of General Psychiatry. 2000;57:867–872. doi: 10.1001/archpsyc.57.9.867. [DOI] [PubMed] [Google Scholar]
  18. Birmaher B, Kaufman J, Brent DA, Dahl RE, Perel JM, al-Shabbout M, Nelson B, Stull S, Rao U, Waterman GS, Williamson DE, Ryan ND. Neuroendocrine response to 5-hydroxy-L-tryptophan in prepubertal children at high risk of major depressive disorder. Archives of General Psychiatry. 1997;54:1113–1119. doi: 10.1001/archpsyc.1997.01830240073010. [DOI] [PubMed] [Google Scholar]
  19. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, Perel J, Nelson B. Childhood and adolescent depression: A review of the past 10 years. Part I. Journal of the American Academy of Child and Adolescent Psychiatry. 1996a;35:1427–1439. doi: 10.1097/00004583-199611000-00011. [DOI] [PubMed] [Google Scholar]
  20. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J. Childhood and adolescent depression: A review of the past 10 years. Part II. Journal of the American Academy of Child and Adolescent Psychiatry. 1996b;35:1575–1583. doi: 10.1097/00004583-199612000-00008. [DOI] [PubMed] [Google Scholar]
  21. Birmaher B, Waterman S, Ryan ND, Perel J, McNabb J, Balach L, Beaudry MB, Nasr FN, Karambelkar J, Elterich G, Quintana H, Williamson DE, Rao U. Randomized, controlled trial of amitriptyline versus placebo for adolescents with “treatment-resistant” major depression. Journal of the American Academy of Child and Adolescent Psychiatry. 1998;37:527–535. doi: 10.1097/00004583-199805000-00015. [DOI] [PubMed] [Google Scholar]
  22. Birmaher B, Williamson DE, Dahl RE, Axelson DA, Kaufman J, Dorn LD, Ryan ND. Clinical presentation and course of depression in youth: Does onset in childhood differ from onset in adolescence? Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:63–70. doi: 10.1097/00004583-200401000-00015. [DOI] [PubMed] [Google Scholar]
  23. Bland ST, Schmid MJ, Der-Avakian A, Watkins LR, Spencer RL, Maier SF. Expression of c-fos and BDNF mRNA in subregions of the prefrontal cortex of male and female rats after acute uncontrollable stress. Brain Research. 2005;1051:90–99. doi: 10.1016/j.brainres.2005.05.065. [DOI] [PubMed] [Google Scholar]
  24. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. American Journal of Psychiatry. 1994;151:979–986. doi: 10.1176/ajp.151.7.979. [DOI] [PubMed] [Google Scholar]
  25. Blumberg HP, Kaufman J, Martin A, Charney DS, Krystal JH, Peterson BS. Significance of adolescent neurodevelopment for the neural circuitry of bipolar disorder. Annals of the New York Academy of Sciences. 2004;1021:376–383. doi: 10.1196/annals.1308.048. [DOI] [PubMed] [Google Scholar]
  26. Blumberg HP, Kaufman J, Martin A, Whiteman R, Zhang JH, Gore JC, Charney DS, Krystal JH, Peterson BS. Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Archives of General Psychiatry. 2003a;60:1201–1208. doi: 10.1001/archpsyc.60.12.1201. [DOI] [PubMed] [Google Scholar]
  27. Blumberg HP, Martin A, Kaufman J, Leung HC, Skudlarski P, Lacadie C, Fulbright RK, Gore JC, Charney DS, Krystal JH, Peterson BS. Frontostriatal abnormalities in adolescents with bipolar disorder: Preliminary observations from functional MRI. American Journal of Psychiatry. 2003b;160:1345–1347. doi: 10.1176/appi.ajp.160.7.1345. [DOI] [PubMed] [Google Scholar]
  28. Botteron KN, Raichle ME, Drevets WC, Heath AC, Todd RD. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biological Psychiatry. 2002;15:342–344. doi: 10.1016/s0006-3223(01)01280-x. [DOI] [PubMed] [Google Scholar]
  29. Boulos C, Kutcher S, Marton P, Simeon J, Ferguson B, Roberts N. Response to desipramine treatment in adolescent major depression. Psychopharmacology Bulletin. 1991;27:59–65. [PubMed] [Google Scholar]
  30. Brent DA. The rewards of reducing risk. Archives of Pediatric Adolescent Medicine. 2004;158:824–825. doi: 10.1001/archpedi.158.8.824. [DOI] [PubMed] [Google Scholar]
  31. Brent DA, Baugher M, Bridge J, Chen T, Chiappetta L. Age- and sex-related risk factors for adolescent suicide. Journal of the American Academy of Child and Adolescent Psychiatry. 1999;38:1497–1505. doi: 10.1097/00004583-199912000-00010. [DOI] [PubMed] [Google Scholar]
  32. Brent DA, Holder D, Kolko D, Birmaher B, Baugher M, Roth C, Iyengar S, Johnson BA. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry. 1997;54:877–885. doi: 10.1001/archpsyc.1997.01830210125017. [DOI] [PubMed] [Google Scholar]
  33. Brent DA, Moritz G, Liotus L, Schweers J, Balach L, Roth C, Perper JA. Familial risk factors for adolescent suicide: A case-control study. In: Kosky RJ, Eshkevari HS, editors. Suicide prevention: The global context. NY: NY: Plenum Press; 1998. pp. 41–50. [Google Scholar]
  34. Brown TA, DeNardo PA, Lehman CL, Campbell LA. Reliability of DSM-IV anxiety and mood disorders: Implications for the classification of emotional disorders. Journal of Abnormal Psychology. 2001;110:49–58. doi: 10.1037//0021-843x.110.1.49. [DOI] [PubMed] [Google Scholar]
  35. Brown Y, Cohn P, Johnson JG, Smailes EM. Child abuse and neglect: Specificity and effects on adolescent and young adult depression and suicidality. Journal of the American Academy of Child and Adolescent Psychiatry. 1999;38:1490–1496. doi: 10.1097/00004583-199912000-00009. [DOI] [PubMed] [Google Scholar]
  36. Brumback RA, Weinberg WA. Pediatric behavioral neurology: An update on the neurological aspects of depression, hyperactivity, and learning disabilities. Neurologic Clinics. 1990;8:677–703. [PubMed] [Google Scholar]
  37. Burcescu I, Wigg K, King N, Vetró Á, Kiss E, Katay L, Kennedy JL, Kovacs M, Barr CL The International Consortium for Childhood-Onset Mood Disorders. Association study of CREB1 and childhood-onset mood disorders. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 2005;137B:45–50. doi: 10.1002/ajmg.b.30201. [DOI] [PubMed] [Google Scholar]
  38. Cacioppo JT. Social neuroscience: Understanding the pieces fosters understanding the whole and vice versa. American Psychologist. 2002;57:819–831. doi: 10.1037/0003-066x.57.11.819. [DOI] [PubMed] [Google Scholar]
  39. Calkins SD, Fox NA. Self-regulatory processes in early personality development: A multilevel approach to the study of childhood social withdrawal and aggression. Developmental Psychopathology. 2002;14:477–498. doi: 10.1017/s095457940200305x. [DOI] [PubMed] [Google Scholar]
  40. Campbell SB, Cohn JF, Meyers T. Depression in first-time mothers: Mother-infant interaction and depression chronicity. Developmental Psychology. 1995;31:349–357. [Google Scholar]
  41. Chamberlin TC. The method of multiple working hypotheses. Science. 1965;148:754–759. doi: 10.1126/science.148.3671.754. (Original work published in 1890) [DOI] [PubMed] [Google Scholar]
  42. Chambers WJ, Puig-Antich J, Hirsch M, Paez P, Ambrosini PJ, Tabrizi MA, Davies M. The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the Schedule for affective disorders and schizophrenia for school-age children, present episode version. Archives of General Psychiatry. 1985;42:696–702. doi: 10.1001/archpsyc.1985.01790300064008. [DOI] [PubMed] [Google Scholar]
  43. Chambless DL, Hollon SD. Defining empirically supported therapies. Journal of Consulting and Clinical Psychology. 1998;66:7–18. doi: 10.1037//0022-006x.66.1.7. [DOI] [PubMed] [Google Scholar]
  44. Charney DS, Barlow DH, Botteron KN, Cohen JD, Goldman D, Gur RC. Neuroscience research agenda to guide development of a pathophysiologically based classification system. In: Kupfer DJ, First MB, Regier DA, editors. A research agenda for DSM-V. Washington, DC: American Psychiatric Association; 2002. pp. 31–83. [Google Scholar]
  45. Chen HH, Nicoletti MA, Hatch JP, Sassi RB, Axelson D, Brambilla P, Monkul ES, Keshavan MS, Ryan ND, Birmaher B, Soares JC. Abnormal left superior temporal gyrus volumes in children and adolescents with bipolar disorder: A magnetic resonance imaging study. Neuroscience Letters. 2004a;363:65–68. doi: 10.1016/j.neulet.2004.03.042. [DOI] [PubMed] [Google Scholar]
  46. Chen BK, Sassi R, Axelson D, Hatch JP, Sanches M, Nicoletti M, Brambilla P, Keshavan MS, Ryan ND, Birmaher B, Soares JC. Cross-sectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biological Psychiatry. 2004b;56:399–405. doi: 10.1016/j.biopsych.2004.06.024. [DOI] [PubMed] [Google Scholar]
  47. Cicchetti D, Toth SL. The development of depression in children and adolescents. American Psychologist. 1998;53:221–241. doi: 10.1037//0003-066x.53.2.221. [DOI] [PubMed] [Google Scholar]
  48. Chess S, Thomas A. Origins and evolution of behavior disorders: From infancy to early adult life. New York: NY: Brunner/Mazel; 1984. [DOI] [PubMed] [Google Scholar]
  49. Clarke GN. Prevention of depression in at-risk samples of adolescents. In: Essau CA, Petermann F, et al., editors. Depressive disorders in children and adolescents: Epidemiology, risk factors, and treatment. Northvale, NJ: Jason Aronson, Inc.; 1999. pp. 341–360. [Google Scholar]
  50. Clarke GN, Hawkins W, Murphy M, Sheeber LB, Lewinsohn PM, Seeley JR. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: A randomized trial of group cognitive intervention. Journal of the American Academy of Child and Adolescent Psychiatry. 1995;34:312–321. doi: 10.1097/00004583-199503000-00016. [DOI] [PubMed] [Google Scholar]
  51. Clarke GN, Hawkins W, Murphy M, Sheeber L. School-based primary prevention of depressive symptomatology in adolescents: Findings from two studies. Journal of Adolescent Research. 1993;8:183–204. [Google Scholar]
  52. Clarke GN, Hornbrook M, Lynch F, Polen M, Gale J, Beardslee W, O'Connor E, Seeley J. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Archives of General Psychiatry. 2001;58:1127–1134. doi: 10.1001/archpsyc.58.12.1127. [DOI] [PubMed] [Google Scholar]
  53. Clarke GN, Lewinsohn PM. The coping with depression course: A group psychoeducational intervention for unipolar depression. Behaviour Change. 1989;6:54–69. [Google Scholar]
  54. Cohn JF, Matias R, Tronick EZ, Donnell D, Lyons-Ruth K. Face-to-face interactions, spontaneous and structured, of mothers with depressive symptoms. In: Field T, Tronick E, editors. Maternal depression and infant disturbance. Vol. 34. New Directions for Child Development; 1986. pp. 31–46. [DOI] [PubMed] [Google Scholar]
  55. Cole DA, Jacquez FM, Maschman TL. Social origins of depressive cognitions: A longitudinal study of self-perceived competence in children. Cognitive Therapy and Research. 2001;25:377–395. [Google Scholar]
  56. Cole DA, Truglio R, Peeke L. Relation between symptoms of anxiety and depression in children: A multitrait-multimethod-multigroup assessment. Journal of Consulting and Clinical Psychology. 1997;65:110–119. doi: 10.1037//0022-006x.65.1.110. [DOI] [PubMed] [Google Scholar]
  57. Coplan JD, Wolk SI, Goetz RR, Ryan ND, Dahl RE, Mann JJ, Weissman MM. Nocturnal growth hormone secretion studies in adolescents with or without major depression re-examined: Integration of adult clinical follow-up data. Biological Psychiatry. 2000;47:594–604. doi: 10.1016/s0006-3223(00)00226-2. [DOI] [PubMed] [Google Scholar]
  58. Coyle JT, Pine DS, Charney DS, Lewis L, Nemeroff CB, Carlson GA, Joshi PT, Reiss D, Todd RD, Hellander M. Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42:1494–1503. doi: 10.1097/00004583-200312000-00017. [DOI] [PubMed] [Google Scholar]
  59. Curry JF, Craighead WE. Attributional style in clinically depressed and conduct disordered adolescents. Journal of Clinical and Consulting Psychology. 1990;58:109–116. doi: 10.1037//0022-006x.58.1.109. [DOI] [PubMed] [Google Scholar]
  60. Dahl RE. Adolescent brain development: A period of vulnerabilities and opportunities. Annals of the New York Academy of Science. 2004;1021:1–22. doi: 10.1196/annals.1308.001. [DOI] [PubMed] [Google Scholar]
  61. Dahl RE. The development of disorders of sleep. Advances in Pediatrics. 1998;45:73–90. [PubMed] [Google Scholar]
  62. Dahl RE, Birmaher B, Williamson DE, Dorn L, Perel L, Kaufman J, Brent DA, Axelson DA, Ryan ND. Low growth hormone response to growth-hormone-releasing hormone in child depression. Biological Psychiatry. 2000;48:981–988. doi: 10.1016/s0006-3223(00)00932-x. [DOI] [PubMed] [Google Scholar]
  63. Dahl RE, Ryan ND, Matty MK, Birmaher B, al-Shabbout M, Williamson DE, Kupfer DJ. Sleep onset abnormalities in depressed adolescents. Biological Psychiatry. 1996;39:400–410. doi: 10.1016/0006-3223(95)00190-5. [DOI] [PubMed] [Google Scholar]
  64. Dahl RE, Ryan ND, Puig-Antich J, Nguyen NA, al-Shabbout M, Meyer VA, Perel J. 24-hour cortisol measures in adolescents with major depression: A controlled study. Biological Psychiatry. 1991;30:25–36. doi: 10.1016/0006-3223(91)90067-v. [DOI] [PubMed] [Google Scholar]
  65. Dahl RE, Ryan ND, Williamson DE, Ambrosini PJ, Rabinovich H, Navacenko H, Nelson B, Puig-Antich J. Regulation of sleep and growth hormone in adolescent depression. Journal of the American Academy of Child and Adolescent Psychiatry. 1992;31:615–621. doi: 10.1097/00004583-199207000-00007. [DOI] [PubMed] [Google Scholar]
  66. Daley SE, Hammen C, Rao A. Predictors of first onset and recurrence of major depression in young women during the 5 years following high school graduation. Journal of Abnormal Psychology. 2000;109:525–533. [PubMed] [Google Scholar]
  67. Davidson RJ, Lewis DA, Alloy LB, Amaral DG, Bush G, Cohen JD, Drevets WC, Farah MJ, Kagan J, McClelland JL, Nolen-Hoeksema S, Peterson BS. Neural and behavioral substrates of mood and mood regulation. Biological Psychiatry. 2002;52:478–502. doi: 10.1016/s0006-3223(02)01458-0. [DOI] [PubMed] [Google Scholar]
  68. Davis B, Sheeber L, Hops H, Tildesley E. Adolescent responses to depressive parental behaviors in problem-solving interactions: Implications for depressive symptoms. Journal of Abnormal Child Psychology. 2000;28:451–465. doi: 10.1023/a:1005183622729. [DOI] [PubMed] [Google Scholar]
  69. Dawson G, Frey K, Panagiotides H, Osterling J. Infants of depressed mothers exhibit atypical frontal brain activity: A replication and extension of previous findings. Journal of Child Psychology and Psychiatry and Allied Disciplines. 1997a;38:179–186. doi: 10.1111/j.1469-7610.1997.tb01852.x. [DOI] [PubMed] [Google Scholar]
  70. Dawson G, Frey K, Panagiotides H, Yamada E, Hessl D, Osterling J. Infants of depressed mothers exhibit atypical frontal electrical brain activity during interactions with mother and with a familiar, nondepressed adult. Child Development. 1999a;70:1058–1066. doi: 10.1111/1467-8624.00078. [DOI] [PubMed] [Google Scholar]
  71. Dawson G, Frey K, Self J, Panagiotides H, Hessl D, Yamada E, Rinaldi J. Frontal brain electrical activity in infants of depressed and nondepressed mothers: Relation to variation in infant behavior. Development and Psychopathology. 1999b;11:589–605. doi: 10.1017/s0954579499002229. [DOI] [PubMed] [Google Scholar]
  72. Dawson G, Panagiotides H, Klinger LG, Spieker S. Infants of depressed and nondepressed mothers exhibit differences in frontal brain electrical activity during the expression of negative emotions. Developmental Psychology. 1997b;33:650–656. doi: 10.1037//0012-1649.33.4.650. [DOI] [PubMed] [Google Scholar]
  73. DeBellis MD, Keshavan MS, Beers SR, Hall J, Frustaci K, Masalehdan A, Noll J, Boring AM. Sex differences in brain maturation during childhood and adolescence. Cerebral Cortex. 2001;11:552–557. doi: 10.1093/cercor/11.6.552. [DOI] [PubMed] [Google Scholar]
  74. Dickstein DP, Milham MP, Nugent AC, Drevets WC, Charney DS, Pine DS, Leibenluft E. Frontotemporal alterations in pediatric bipolar disorder: Results of a voxel-based morphometry study. Archives of General Psychiatry. 2005;62:734–741. doi: 10.1001/archpsyc.62.7.734. [DOI] [PubMed] [Google Scholar]
  75. Downey G, Coyne JC. Children of depressed parents: An integrative review. Psychological Bulletin. 1990;108:50–76. doi: 10.1037/0033-2909.108.1.50. [DOI] [PubMed] [Google Scholar]
  76. Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Progress in Brain Research. 2000;126:413–431. doi: 10.1016/S0079-6123(00)26027-5. [DOI] [PubMed] [Google Scholar]
  77. Dryman A, Eaton WW. Affective symptoms associated with the onset of major depression in the community: Findings from the US National Institute of Health Epidemiologic Catchment Area Program. Acta Psychiatry Scandanavia. 1991;84:1–5. doi: 10.1111/j.1600-0447.1991.tb01410.x. [DOI] [PubMed] [Google Scholar]
  78. Duman RS. Pathophysiology of depression: The concept of synaptic plasticity. European Psychiatry. 2002;17:306–310. doi: 10.1016/s0924-9338(02)00654-5. [DOI] [PubMed] [Google Scholar]
  79. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry. 1997;54:1031–1037. doi: 10.1001/archpsyc.1997.01830230069010. [DOI] [PubMed] [Google Scholar]
  80. Engström C, Thornlund AS, Johansson EL, Langström, M, Chotai J, Adolfsson R, Nylander PO. Anticipation in unipolar affective disorder. Journal of Affective Disorders. 1995;35:31–40. doi: 10.1016/0165-0327(95)00035-l. [DOI] [PubMed] [Google Scholar]
  81. Farmer A, Mahmood A, Redman K, Harris T, Sadler S, McGuffin P. A sib-pair study of the Temperament and Character Inventory scales in major depression. Archives of General Psychiatry. 2003;60:490–496. doi: 10.1001/archpsyc.60.5.490. [DOI] [PubMed] [Google Scholar]
  82. Fawcett J, Clark DC, Scheftner WA, Gibbons RD. Assessing anhedonia in psychiatric patients. Archives of General Psychiatry. 1983;40:79–84. doi: 10.1001/archpsyc.1983.01790010081010. [DOI] [PubMed] [Google Scholar]
  83. Feder A, Coplan JD, Goetz RR, Mathew SJ, Pine DS, Dahl RE, Ryan ND, Greenwald S, Weissman MM. Twenty-four-hour cortisol secretion patterns in prepubertal children with anxiety or depressive disorders. Biological Psychiatry. 2004;56:198–204. doi: 10.1016/j.biopsych.2004.05.005. [DOI] [PubMed] [Google Scholar]
  84. Feehan M, McGee R, Raja SN, Williams SM. DSM-III-R disorders in New Zealand 18-year-olds. Australian & New Zealand Journal of Psychiatry. 1994;28:87–99. doi: 10.3109/00048679409075849. [DOI] [PubMed] [Google Scholar]
  85. Fendrich M, Warner V, Weissman MM. Family risk factors, parental depression, and psychopathology in offspring. Developmental Psychology. 1990;26:40–50. [Google Scholar]
  86. Field T. Massage therapy. Medical Clinics of North America. 2002;86:163–171. doi: 10.1016/s0025-7125(03)00078-6. [DOI] [PubMed] [Google Scholar]
  87. Field T, Fox NA, Pickens J, Nawrocki T. Relative right frontal EEG activation in 3-month-old to 6-month-old infants of depressed mothers. Developmental Psychology. 1995;31:358–363. [Google Scholar]
  88. Field T, Healy B, Goldstein S, Guthertz M. Behavior-state matching and synchrony in mother-infant interactions of non-depressed versus depressed dads. Developmental Psychology. 1990;26:7–14. [Google Scholar]
  89. Focht L, Beardslee WR. “Speech after long silence”: The use of narrative therapy in a preventive intervention for children of parents with affective disorder. Family Process. 1996;35:407–422. doi: 10.1111/j.1545-5300.1996.00407.x. [DOI] [PubMed] [Google Scholar]
  90. Frank E, Swartz HA, Kupfer DJ. Interpersonal and social rhythm therapy: Managing the chaos of bipolar disorder. Biological Psychiatry. 2000;48:593–604. doi: 10.1016/s0006-3223(00)00969-0. [DOI] [PubMed] [Google Scholar]
  91. Freres DR, Gillham JE, Reivich K, Shatte AJ. Preventing depressive symptoms in middle school students: The Penn Resiliency Program. International Journal of Emergency Mental Health. 2002;4:31–40. [PubMed] [Google Scholar]
  92. Garber J, Braafladt N, Weiss B. Affect regulation in depressed and nondepressed children and young adolescents. Development and Psychopathology. 1995;7:93–115. [Google Scholar]
  93. Garber J, Dodge KA, editors. The development of emotion regulation and dysregulation. New York: NY: Cambridge University Press; 1991. [Google Scholar]
  94. Garber J, Martin N, Keiley M. Paper presented at the meeting of the Child Depression Consortium. Pittsburgh, PA: 1999. Psychosocial predictors of the onset of mood disorders in young adolescents. [Google Scholar]
  95. Garber J, Keiley MK, Martin C. Developmental trajectories of adolescents' depressive symptoms: Predictors of change. Journal of Consulting and Clinical Psychology. 2002;70:79–95. doi: 10.1037//0022-006x.70.1.79. [DOI] [PubMed] [Google Scholar]
  96. Geller B, Cooper TB, Graham DL, Marsteller FA, Bryant DM. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a “fixed plasma level” design. Psychopharmacology Bulletin. 1990;26:85–91. [PubMed] [Google Scholar]
  97. Geller B, Cooper TB, McCombs HG, Graham D, Wells J. Double-blind, placebo-controlled study of nortriptyline in depressed children using a “fixed plasma level” design. Psychopharmacology Bulletin. 1989;25:101–109. [PubMed] [Google Scholar]
  98. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL. Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. American Journal of Psychiatry. 2001a;158:125–127. doi: 10.1176/appi.ajp.158.1.125. [DOI] [PubMed] [Google Scholar]
  99. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL. Adult psychosocial outcome of prepubertal major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2001b;40:673–677. doi: 10.1097/00004583-200106000-00012. [DOI] [PubMed] [Google Scholar]
  100. Gillham JE, Reivich KJ. Prevention of depressive symptoms in school children: A research update. Psychological Science. 1999;10:461–462. [Google Scholar]
  101. Gillham JE, Reivich KJ, Jaycox LH, Seligman MEP. Prevention of depressive symptoms in schoolchildren: Two-year follow-up. Psychological Science. 1995;6:343–351. [Google Scholar]
  102. Gladstone TRG, Beardslee WR. The prevention of depression in at-risk adolescents: Current and future directions. Journal of Cognitive Psychotherapy. 2000;14:9–23. [Google Scholar]
  103. Gladstone TR, Kaslow NJ, Seeley JR, Lewinsohn PM. Sex differences, attributional style, and depressive symptoms among adolescents. Journal of Abnormal Child Psychology. 1997;25:297–306. doi: 10.1023/a:1025712419436. [DOI] [PubMed] [Google Scholar]
  104. Gold PW, Goodwin FK, Chorousos GP. Clinical and biochemical manifestations of depression: Relations to the neurobiology of stress I. New England Journal of Medicine. 1988a;319:348–353. doi: 10.1056/NEJM198808113190606. [DOI] [PubMed] [Google Scholar]
  105. Gold PW, Goodwin FK, Chorousos GP. Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress II. New England Journal of Medicine. 1988b;319:413–420. doi: 10.1056/NEJM198808183190706. [DOI] [PubMed] [Google Scholar]
  106. Goldstein MJ. Transactional processes associated with relatives’ expressed emotion. International Journal of Mental Health. 1995;24:76–96. [Google Scholar]
  107. Gotlib IH, Lewinsohn PM, Seeley JR. Symptoms versus a diagnosis of depression: differences in psychosocial functioning. Journal of Consulting & Clinical Psychology. 1995;63:90–100. doi: 10.1037//0022-006x.63.1.90. [DOI] [PubMed] [Google Scholar]
  108. Gottman J. The heart of parenting: Raising an emotionally intelligent child. New York: NY: Simon and Schuster; 1997. [Google Scholar]
  109. Graham CA, Easterbrooks MA. School-aged children’s vulnerability to depressive symptomatology: The role of attachment security, maternal depressive symptomatology, and economic risk. Development and Psychopathology. 2000;12:201–213. doi: 10.1017/s0954579400002054. [DOI] [PubMed] [Google Scholar]
  110. Gullion CM, Rush AJ. Toward a generalizable model of symptoms in major depressive disorder. Biological Psychiatry. 1998;44:959–972. doi: 10.1016/s0006-3223(98)00235-2. [DOI] [PubMed] [Google Scholar]
  111. Gunnar MR. Integrating neuroscience and psychological approaches in the study of early experiences. Annals of the New York Academy of Science. 2003;1008:238–247. doi: 10.1196/annals.1301.024. [DOI] [PubMed] [Google Scholar]
  112. Gutgesell H, Atkins D, Barst R, et al. American Health Association scientific statement: Cardiovascular monitoring of children and adolescents receiving psychotropic drugs. Journal of the American Academy of Child and Adolescent Psychiatry. 1999;38:1047–1050. doi: 10.1097/00004583-199908000-00022. [DOI] [PubMed] [Google Scholar]
  113. Hammen C. Depression runs in families: The social context of risk and resilience in children of depressed mothers. New York: NY: Springer-Verlag; 1991. [Google Scholar]
  114. Harmon-Jones E, Devine PG. Introduction to the special section on social neuroscience: Promise and caveats. Journal of Personality and Social Psychology. 2003;85:589–593. doi: 10.1037/0022-3514.85.4.589. [DOI] [PubMed] [Google Scholar]
  115. Harrington RC, Bredenkamp D, Groothues C, Rutter M, Fudge H, Pickles A. Adult outcomes of childhood and adolescent depression. III: Links with suicidal behaviours. Journal of Child Psychology and Psychiatry. 1994;35:1380–1391. doi: 10.1111/j.1469-7610.1994.tb01236.x. [DOI] [PubMed] [Google Scholar]
  116. Harrington R, Clark A. Prevention and early intervention for depression in adolescence and early adult life. European Archives of Psychiatry and Clinical Neuroscience. 1998;248:32–45. doi: 10.1007/s004060050015. [DOI] [PubMed] [Google Scholar]
  117. Harrington R, Fudge H, Rutter M, Pickles A, Hill J. Adult outcomes of childhood and adolescent depression. I: Psychiatric status. Archives of General Psychiatry. 1990;47:465–473. doi: 10.1001/archpsyc.1990.01810170065010. [DOI] [PubMed] [Google Scholar]
  118. Harrington R, Kerfoot M, Dyer E, McNiven F, Gill J, Harrington V, Woodham A, Byford S. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry. 1998;37:512–518. [PubMed] [Google Scholar]
  119. Harrington R, Vostanis P. Longitudinal perspectives and affective disorder in children and adolescents. In: Goodyer IM, editor. The depressed child and adolescent: Developmental and clinical perspectives. Cambridge: Cambridge University Press; 1995. pp. 311–341. [Google Scholar]
  120. Harrington R, Whittaker J, Shoebridge P. Psychological treatment of depression in children and adolescents: A review of treatment research. British Journal of Psychiatry. 1998;173:291–298. doi: 10.1192/bjp.173.4.291. [DOI] [PubMed] [Google Scholar]
  121. Hasler G, Drevets WC, Manji HK, Charney DS. Discovering endophenotypes for major depression. Neuropsychopharmacology. 2004;29:1765–1781. doi: 10.1038/sj.npp.1300506. [DOI] [PubMed] [Google Scholar]
  122. Hazell P, O’Connell D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis. British Medical Journal. 1995;310:897–901. doi: 10.1136/bmj.310.6984.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Hibbs ED, Jensen PS. Psychosocial treatments for child and adolescent disorders: Empirically based strategies for clinical practice. Washington, DC: American Psychological Association; 1996. [Google Scholar]
  124. Hien D, Matzner FJ, First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-Child Edition (K-SCID, Version 1.0) New York: NY: Biometrics Research Department, New York State Psychiatric Institute; 1998. [Google Scholar]
  125. Hillsman R, Garber J. A test of the cognitive diathesis-stress model of depression in children: Academic stressors, attributional style, perceived competence, and control. Journal of Personality and Social Psychology. 1995;69:370–380. doi: 10.1037//0022-3514.69.2.370. [DOI] [PubMed] [Google Scholar]
  126. Hollon SD, Munoz RF, Barlow DH, Beardslee WR, Bell CC, Bernal G, Clarke GN, Franciosi LP, Kazdin AE, Kohn L, Linehan MM, Markowitz JC, Miklowitz DJ, Persons JB, Niederehe G, Sommers D. Psychosocial intervention development for the prevention and treatment of depression: Promoting innovation and increasing access. Biological Psychiatry. 2002;15:610–630. doi: 10.1016/s0006-3223(02)01384-7. [DOI] [PubMed] [Google Scholar]
  127. Hughes CW, Emslie GJ, Grismon ML, Wagner KD, Birmaher B, Geller B, Pliszka SR, Ryan ND, Strober M, Trivedi MH, Toprac MG, Sedillo A, Llana ME, Lopez M, Rush AJ. The Texas Children’s Medication Algorithm Project: Report of the Texas consensus conference panel on medication treatment of childhood major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 1999;38:1442–1454. doi: 10.1097/00004583-199911000-00020. [DOI] [PubMed] [Google Scholar]
  128. Hughes CW, Preskorn SH. Depressive syndromes in children and adolescents: Diagnosis and treatment. Annals of Clinical Psychiatry. 1989;1:109–118. [Google Scholar]
  129. Hughes CW, Preskorn SH, Weller E, Weller R, Hassanein R, Tucker S. Effect of concomitant disorders in childhood depression on predicting treatment response. Psychopharmacology Bulletin. 1990;26:235–238. [PubMed] [Google Scholar]
  130. Jacobs GD. The physiology of mind-body interactions: The stress response and the relaxation response. Journal of Alternative and Complementary Medicine. 2001;7:S83–S92. doi: 10.1089/107555301753393841. [DOI] [PubMed] [Google Scholar]
  131. Jacobsen CF. Functions of the frontal association area in primates. Archives of Neurology and Psychiatry. 1935;33:558–569. [Google Scholar]
  132. Jameson PB, Gelfand DM, Kulcsar E, Teti DM. Mother-toddler interaction patterns associated with maternal depression. Developmental Psychopathology. 1997;9:537–550. [PubMed] [Google Scholar]
  133. Jardine R, Martin NG, Henderson AS. Genetic covariation between neuroticism and the symptoms of anxiety and depression. Genetic Epidemiology. 1984;1:89–107. doi: 10.1002/gepi.1370010202. [DOI] [PubMed] [Google Scholar]
  134. Jaycox LH, Reivich KJ, Gillham J, Seligman MEP. Prevention of depressive symptoms in school children. Behaviour Research and Therapy. 1994;32:801–816. doi: 10.1016/0005-7967(94)90160-0. [DOI] [PubMed] [Google Scholar]
  135. Jensen PS, Bloedau L, Degroot J, Ussery T. Children at risk: I. Risk factors and child symptomatology. Journal of the American Academy of Child and Adolescent Psychiatry. 1990;29:51–59. doi: 10.1097/00004583-199001000-00010. [DOI] [PubMed] [Google Scholar]
  136. Kaminski KM, Garber J. Depressive spectrum disorders in high-risk adolescents: Episode duration and predictors of time to recovery. Journal of the American Academy of Child and Adolescent Psychiatry. 2002;41:410–418. doi: 10.1097/00004583-200204000-00013. [DOI] [PubMed] [Google Scholar]
  137. Kaplan SJ, Pelcovitz D, Salzinger S, Weiner M, Mandel FS, Lesser ML, Labruna VE. Adolescent physical abuse: Risk for adolescent psychiatric disorders. American Journal of Psychiatry. 1998;155:954–959. doi: 10.1176/ajp.155.7.954. [DOI] [PubMed] [Google Scholar]
  138. Kaslow NJ, Rehm LP, Pollack SL, Siegel AW. Attributional style and self-control behavior in depressed and nondepressed children and their parents. Journal of Abnormal Child Psychology. 1998;16:163–175. doi: 10.1007/BF00913592. [DOI] [PubMed] [Google Scholar]
  139. Kaufman J. Depressive disorders in maltreated children. Journal of the American Academy of Child and Adolescent Psychiatry. 1991;30:257–265. doi: 10.1097/00004583-199103000-00014. [DOI] [PubMed] [Google Scholar]
  140. Kaufman J, Martin A, King R, Charney D. Are child-, adolescent-, and adult-onset depression one and the same disorder? Biological Psychiatry. 2001;49:980–1001. doi: 10.1016/s0006-3223(01)01127-1. [DOI] [PubMed] [Google Scholar]
  141. Kazdin AE, Moser J, Colbus D, Bell R. Depressive symptoms among physically abused and psychiatrically disturbed children. Journal of Abnormal Psychology. 1985;94:298–307. doi: 10.1037//0021-843x.94.3.298. [DOI] [PubMed] [Google Scholar]
  142. Kazdin AE, Weisz JR. Identifying and developing empirically supported child and adolescent treatments. Journal of Consulting and Clinical Psychology. 1998;66:19–36. doi: 10.1037//0022-006x.66.1.19. [DOI] [PubMed] [Google Scholar]
  143. Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack W, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP. Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:762–772. doi: 10.1097/00004583-200107000-00010. [DOI] [PubMed] [Google Scholar]
  144. Kendall PC, Stark KD, Adam T. Cognitive deficit or cognitive distortion in childhood depression. Journal of Abnormal Child Psychology. 1990;18:255–270. doi: 10.1007/BF00916564. [DOI] [PubMed] [Google Scholar]
  145. Kendler KS, Gardner CO, Prescott CA. Clinical characteristics of major depression that predict risk of depression in relatives. Archives of General Psychiatry. 1999;56:322–327. doi: 10.1001/archpsyc.56.4.322. [DOI] [PubMed] [Google Scholar]
  146. Kendler KS, Heath AC, Martin NG, Lindon JE. Symptoms of anxiety and depression in a volunteer twin population. Archives of General Psychiatry. 1986;43:213–221. doi: 10.1001/archpsyc.1986.01800030023002. [DOI] [PubMed] [Google Scholar]
  147. Kendler KS, Thornton LM, Prescott CA. Gender differences in the rates of exposure to stressful life events and sensitivity to their depressogenic effects. American Journal of Psychiatry. 2001;158:587–593. doi: 10.1176/appi.ajp.158.4.587. [DOI] [PubMed] [Google Scholar]
  148. Kentgen LM, Tenke CE, Pine DS, Fong R, Klein RG, Bruder GE. Electroencephalographic asymmetries in adolescents with major depression: Influence of comorbidity with anxiety disorders. Journal of Abnormal Psychology. 2000;109:797–802. doi: 10.1037//0021-843x.109.4.797. [DOI] [PubMed] [Google Scholar]
  149. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. Journal of Affective Disorders. 1993;29:85–96. doi: 10.1016/0165-0327(93)90026-g. [DOI] [PubMed] [Google Scholar]
  150. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51:8–19. doi: 10.1001/archpsyc.1994.03950010008002. [DOI] [PubMed] [Google Scholar]
  151. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depression and Anxiety. 1998;7:3–14. doi: 10.1002/(sici)1520-6394(1998)7:1<3::aid-da2>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  152. Klein DN, Lewinsohn PM, Seeley JR, Rohde P. A family study of major depressive disorder in a community sample of adolescents. Archives of General Psychiatry. 2001;58:13–20. doi: 10.1001/archpsyc.58.1.13. [DOI] [PubMed] [Google Scholar]
  153. Klein RG, Mannuzza S, Koplewicz HS, Tancer NK, Shah M, Liang V, Davies M. Adolescent depression: Controlled desipramine treatment and atypical features. Depression and Anxiety. 1998;7:15–31. doi: 10.1002/(sici)1520-6394(1998)7:1<15::aid-da3>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  154. Korszun A, Moskvina V, Brewster S, Craddock N, Ferrero F, Gill M, Jones IR, Jones LA, Maier W, Mors O, Owen MJ, Preisig M, Reich T, Rietschel M, Farmer A, McGuffin P. Familiality of symptom dimensions in depression. Archives of General Psychiatry. 2004;61:468–474. doi: 10.1001/archpsyc.61.5.468. [DOI] [PubMed] [Google Scholar]
  155. Kovacs M. Presentation and course of major depressive disorder during childhood and later years of the life span. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:705–715. doi: 10.1097/00004583-199606000-00010. [DOI] [PubMed] [Google Scholar]
  156. Kovacs M. Depressive disorders in childhood: An impressionistic landscape. Journal of Child Psychology and Psychiatry. 1997a;38:287–298. doi: 10.1111/j.1469-7610.1997.tb01513.x. [DOI] [PubMed] [Google Scholar]
  157. Kovacs M. Chronic depression in childhood. In: Akiskal JS, et al., editors. Dysthymia and the spectrum of chronic depressions. New York: NY: Guilford Press; 1997b. [Google Scholar]
  158. Kovacs M, Akiskal HS, Gatsonis C, Parrone PL. Childhood-onset dysthymic disorder: Clinical features and prospective naturalistic outcome. Archives of General Psychiatry. 1994;51:365–374. doi: 10.1001/archpsyc.1994.03950050025003. [DOI] [PubMed] [Google Scholar]
  159. Kovacs M, Devlin B. Internalizing disorders in childhood. Journal of Child Psychology and Psychiatry. 1998;39:47–63. [PubMed] [Google Scholar]
  160. Kovacs M, Devlin B, Pollock M, Richards C, Mukerji P. A controlled family history study of childhood-onset depressive disorder. Archives of General Psychiatry. 1997;54:613–623. doi: 10.1001/archpsyc.1997.01830190033004. [DOI] [PubMed] [Google Scholar]
  161. Kovacs M, Finberg TL, Crouse-Novack MA, Paulauskas SL, Finkelstein R. Depressive disorders in childhood. I: A longitudinal prospective study of characteristics and recovery. Archives of General Psychiatry. 1984a;41:229–237. doi: 10.1001/archpsyc.1984.01790140019002. [DOI] [PubMed] [Google Scholar]
  162. Kovacs M, Feinberg TL, Crouse-Novak M, Paulauskas SL, Pollock M, Finkelstein R. Depressive disorders in childhood. II: A longitudinal study of the risk for a subsequent major depression. Archives of General Psychiatry. 1984b;41:643–649. doi: 10.1001/archpsyc.1984.01790180013001. [DOI] [PubMed] [Google Scholar]
  163. Kovacs M, Gatsonis C, Paulauskas SL, Richards C. Depressive disorders in childhood. IV: A longitudinal study of comorbidity with and risk for anxiety disorders. Archives of General Psychiatry. 1989;46:776–782. doi: 10.1001/archpsyc.1989.01810090018003. [DOI] [PubMed] [Google Scholar]
  164. Kovacs M, Goldston D. Cognitive and social cognitive development of depressed children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 1991;30:388–392. doi: 10.1097/00004583-199105000-00006. [DOI] [PubMed] [Google Scholar]
  165. Kovacs M, Goldston D, Gatsonis C. Suicidal behaviors and childhood-onset depressive disorders: A longitudinal investigation. Journal of the American Academy of Child and Adolescent Psychiatry. 1993;32:8–20. doi: 10.1097/00004583-199301000-00003. [DOI] [PubMed] [Google Scholar]
  166. Kovacs M, Lohr WD. Research on psychotherapy with children and adolescents: An overview of evolving trends and current issues. Journal of Abnormal Psychology. 1995;23:11–30. doi: 10.1007/BF01447042. [DOI] [PubMed] [Google Scholar]
  167. Kovacs M, Obrosky DS, Sherrill J. Developmental changes in the phenomenology of depression in girls and young women from childhood onward. Journal of Affective Disorders. 2003;74:33–48. doi: 10.1016/s0165-0327(02)00429-9. [DOI] [PubMed] [Google Scholar]
  168. Kovacs M, Paulauskas S, Gatsonis C, Richards C. Depressive disorders in childhood. III: A longitudinal study of comorbidity with and risk for conduct disorders. Journal of Affective Disorders. 1988;15:205–217. doi: 10.1016/0165-0327(88)90018-3. [DOI] [PubMed] [Google Scholar]
  169. Kovacs M, Pollock M. Bipolar disorder and comorbid conduct disorder in childhood and adolescence. Journal of the American Academy of Child and Adolescent Psychiatry. 1995;34:715–723. doi: 10.1097/00004583-199506000-00011. [DOI] [PubMed] [Google Scholar]
  170. Kovacs M, Sherrill JT. The psychotherapeutic management of major depressive and dysthymic disorders in childhood and adolescence: Issues and prospects. In: Goodyer IM, editor. The depressed child and adolescent. Cambridge: Cambridge University Press; 2001. pp. 325–352. [Google Scholar]
  171. Kringelbach ML, Rolls ET. The functional neuroanatomy of the human orbitofrontal cortex: Evidence from neuroimaging and neuropsychology. Progress in Neurobiology. 2004;72:341–372. doi: 10.1016/j.pneurobio.2004.03.006. [DOI] [PubMed] [Google Scholar]
  172. Kupfer DJ. The mission of therapeutics. Neuropsychopharmacology. 1993;9:169–180. doi: 10.1038/npp.1993.55. [DOI] [PubMed] [Google Scholar]
  173. Kutcher S, Boulos C, Ward B, Marton P, Simeon J, Ferguson HB, Szalai J, Katic M, Roberts N, Dubois C, Reed K. Response to desipramine treatment in adolescent depression: A fixed-dose, placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry. 1994;33:686–694. doi: 10.1097/00004583-199406000-00010. [DOI] [PubMed] [Google Scholar]
  174. Kye CH, Waterman GS, Ryan ND, Birmaher B, Williamson DE, Iyengar S, Dachille S. A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:1139–1144. doi: 10.1097/00004583-199609000-00011. [DOI] [PubMed] [Google Scholar]
  175. Lahey BB, Applegate B, Waldman ID, Loft JD, Hankin BL, Rick J. The structure of child and adolescent psychopathology: Generating new hypotheses. Journal of Abnormal Psychology. 2004;113:358–385. doi: 10.1037/0021-843X.113.3.358. [DOI] [PubMed] [Google Scholar]
  176. Larson RW, Raffaelli M, Richards MH, Ham M, Jewell L. Ecology of depression in late childhood and early adolescence: A profile of daily states and activities. Journal of Abnormal Psychology. 1990;99:92–102. doi: 10.1037//0021-843x.99.1.92. [DOI] [PubMed] [Google Scholar]
  177. Leibenluft E, Charney DS, Pine DS. Researching the pathophysiology of pediatric bipolar disorder. Biological Psychiatry. 2003;53:1009–1020. doi: 10.1016/s0006-3223(03)00069-6. [DOI] [PubMed] [Google Scholar]
  178. Lewinsohn PM, Allen NB, Seeley JR, Gotlib IH. First onset versus recurrence of depression: Differential processes of psychosocial risk. Journal of Abnormal Psychology. 1999;108:483–489. doi: 10.1037//0021-843x.108.3.483. [DOI] [PubMed] [Google Scholar]
  179. Lewinsohn PM, Clarke GN, Hoberman HM. The coping with depression course: Review and future directions. Canadian Journal of Behavioural Science. 1989;21:470–493. [Google Scholar]
  180. Lewinsohn PM, Clarke GN, Hops H, Andrews J. Cognitive-behavioral treatment of depressed adolescents. Behavior Therapy. 1990;21:385–401. [Google Scholar]
  181. Lewinsohn PM, Clarke GN, Rohde P, Hops H, Seeley JR. A course in coping: A cognitive-behavioral approach to the treatment of adolescent depression. In: Hibbs ED, Jensen PS, editors. Psychosocial treatments for child and adolescent disorders: Empirically based strategies for clinical practice. Washington, DC: American Psychological Association; 1996. pp. 109–135. [Google Scholar]
  182. Lewinsohn PM, Hops H, Roberts RE, Seeley JR, Andrews J. Adolescent psychopathology: Prevalence and incidence of depression and other DSM-III-R disorders in high school students. Journal of Abnormal Psychology. 1993;102:133–144. doi: 10.1037//0021-843x.102.1.133. [DOI] [PubMed] [Google Scholar]
  183. Lewinsohn PM, Joiner TE, Rohde P. Evaluation of cognitive diathesis-stress models in predicting major depressive disorder in adolescents. Journal of Abnormal Psychology. 2001;110:203–215. doi: 10.1037//0021-843x.110.2.203. [DOI] [PubMed] [Google Scholar]
  184. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course. Journal of the American Academy of Child & Adolescent Psychiatry. 1995;34:454–463. [PubMed] [Google Scholar]
  185. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disorders. 2000;2:281–293. doi: 10.1034/j.1399-5618.2000.20309.x. [DOI] [PubMed] [Google Scholar]
  186. Lewinsohn PM, Roberts RE, Seeley JR, Rohde P. Adolescent psychopathology. II: Psychosocial risk factors for depression. Journal of Abnormal Psychology. 1994;103:302–315. doi: 10.1037//0021-843x.103.2.302. [DOI] [PubMed] [Google Scholar]
  187. Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: Prevalence, risk factors, and clinical implications. Clinical Psychology Review. 1998;18:765–794. doi: 10.1016/s0272-7358(98)00010-5. [DOI] [PubMed] [Google Scholar]
  188. Lewinsohn PM, Rohde P, Seeley JR, Hops H. Comorbidity of unipolar depression. I: Major depression with dysthymia. Journal of Abnormal Psychology. 1991;100:205–213. [PubMed] [Google Scholar]
  189. Lewinsohn PM, Rohde P, Seeley JR, Klein DN, Gotlib IH. Natural course of adolescent major depressive disorder in a community sample: Predictors of recurrence in young adults. American Journal of Psychiatry. 2000;157:1584–1591. doi: 10.1176/appi.ajp.157.10.1584. [DOI] [PubMed] [Google Scholar]
  190. Lewinsohn PM, Seeley JR, Hibbard J, Rohde P, Sack WH. Cross-sectional and prospective relationships between physical morbidity and depression in older adolescents. Journal of the American Academy of Child & Adolescent Psychiatry. 1996;35:1120–1129. doi: 10.1097/00004583-199609000-00009. [DOI] [PubMed] [Google Scholar]
  191. Loas G, Boyer P, Legrand A. Anhedonia in the deficit syndrome of schizophrenia. Psychopathology. 1999;32:207–219. doi: 10.1159/000029092. [DOI] [PubMed] [Google Scholar]
  192. MacMillan S, Szeszko PR, Moore GJ, Madden R, Lorch E, Ivey J, Banerjee SP, Rosenberg DR. Increased amygdala-hippocampal volume ratios associated with severity of anxiety in pediatric major depression. Journal of Child and Adolescent Psychopharmacology. 2003;13:65–73. doi: 10.1089/104454603321666207. [DOI] [PubMed] [Google Scholar]
  193. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association. 2004;292:807–820. doi: 10.1001/jama.292.7.807. [DOI] [PubMed] [Google Scholar]
  194. Mathew SJ, Coplan JD, Goetz RR, Feder A, Greenwald S, Dahl RE, Ryan ND, Mann JJ, Weissman MM. Differentiating depressed adolescent 24-hour cortisol secretion in light of their adult clinical outcome. Neuropsychopharmacology. 2003;28:1336–1343. doi: 10.1038/sj.npp.1300184. [DOI] [PubMed] [Google Scholar]
  195. Marazita ML, Neiswanger K, Cooper M, Zubenko GS, Giles DE, Frank E, Kupfer DJ, Kaplan BB. Genetic segregation analysis of early-onset recurrent unipolar depression. American Journal of Human Genetics. 1997;61:1370–1378. doi: 10.1086/301627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Martin A, Kaufman J, Charney D. Pharmacotherapy of early-onset depression. Child and Adolescent Clinics of North America. 2000;9:135–157. [PubMed] [Google Scholar]
  197. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends in Neuroscience. 2004;27:589–592. doi: 10.1016/j.tins.2004.08.001. [DOI] [PubMed] [Google Scholar]
  198. McCauley E, Mitchell JR, Burke P, Moss S. Cognitive attributes of depression in children and adolescents. Journal of Consulting and Clinical Psychology. 1988;56:903–908. doi: 10.1037//0022-006x.56.6.903. [DOI] [PubMed] [Google Scholar]
  199. McCauley E, Myers K, Mitchell J, Calderon R, Schloredt K, Treder R. Depression in young people: Initial presentation and clinical course. Journal of the American Academy of Child and Adolescent Psychiatry. 1993;32:714–722. doi: 10.1097/00004583-199307000-00003. [DOI] [PubMed] [Google Scholar]
  200. McGee R, Feehan M, Williams S, Partridge F, Silva PA, Kelly J. DSM-III disorders in a large sample of adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 1990;29:611–619. doi: 10.1097/00004583-199007000-00016. [DOI] [PubMed] [Google Scholar]
  201. McInnis MG, McMonan FJ, Chase GA, Simpson SG, Ross CA, DePaulo JR. Anticipation in bipolar affective disorder. American Journal of Human Genetics. 1993;53:385–390. [PMC free article] [PubMed] [Google Scholar]
  202. Messer SC, Gross AM. Childhood depression and family interaction: A naturalistic observational study. Journal of Clinical Child Psychology. 1995;24:77–88. [Google Scholar]
  203. Miller A, Fox NA, Cohn JF, Forbes EE, Sherrill JT, Kovacs M. Regional patterns of brain activity in adults with a history of childhood-onset depression: Sex differences and clinical variability. American Journal of Psychiatry. 2002;159:934–940. doi: 10.1176/appi.ajp.159.6.934. [DOI] [PubMed] [Google Scholar]
  204. Miner LH, Schroeter S, Blakely RD, Sesack SR. Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals. Journal of Comparative Neurology. 2000;427:220–234. doi: 10.1002/1096-9861(20001113)427:2<220::aid-cne5>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  205. Mitchell J, McCauley E, Burke P, Calderon R, Schloredt K. Psychopathology in parents of depressed children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 1989;28:352–357. doi: 10.1097/00004583-198905000-00008. [DOI] [PubMed] [Google Scholar]
  206. Mitchell J, McCauley E, Burke PM, Moss SJ. Phenomenology of depression in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 1988;27:12–20. doi: 10.1097/00004583-198801000-00004. [DOI] [PubMed] [Google Scholar]
  207. Monroe SM, Rohde P, Seeley JR, Lewinsohn PM. Life events and depression in adolescence: Relationship loss as a prospective risk factor for first onset of major depressive disorder. Journal of Abnormal Psychology. 1999;108:606–614. doi: 10.1037//0021-843x.108.4.606. [DOI] [PubMed] [Google Scholar]
  208. Mufson L, Weissman MM, Moreau D, Garfinkel R. Efficacy of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry. 1999;56:573–579. doi: 10.1001/archpsyc.56.6.573. [DOI] [PubMed] [Google Scholar]
  209. Murray L, Kempton C, Woolgar M, Hooper R. Depressed mothers’ speech to their infants and its relation to infant gender and cognitive development. Journal of Child Psychology and Psychiatry. 1993;34:1083–1102. doi: 10.1111/j.1469-7610.1993.tb01775.x. [DOI] [PubMed] [Google Scholar]
  210. Nauta WJH. The problem of the frontal lobe: A reinterpretation. Journal of Psychiatric Research. 1971;8:167–187. doi: 10.1016/0022-3956(71)90017-3. [DOI] [PubMed] [Google Scholar]
  211. Nelson CA, Bloom FE, Cameron JL, Amaral D, Dahl RE, Pine D. An integrative, multidisciplinary approach to the study of brain-behavior relations in the context of typical and atypical development. Developmental Psychopathology. 2002;14:499–520. doi: 10.1017/s0954579402003061. [DOI] [PubMed] [Google Scholar]
  212. Nelson JC, Charney DS. The symptoms of major depressive illness. American Journal of Psychiatry. 1981;138:1–13. doi: 10.1176/ajp.138.1.1. [DOI] [PubMed] [Google Scholar]
  213. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34:13–25. doi: 10.1016/s0896-6273(02)00653-0. [DOI] [PubMed] [Google Scholar]
  214. Nestler EJ, Barrot M, Self DW. DeltaFosB: A sustained molecular switch for addiction. Proceedings of the National Academy of Science USA. 2001;98:11042–11046. doi: 10.1073/pnas.191352698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Neuman RJ, Geller B, Rice JP, Todd RD. Increased prevalence and earlier onset of mood disorder among relatives of prepubertal versus adult probands. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:466–473. doi: 10.1097/00004583-199704000-00008. [DOI] [PubMed] [Google Scholar]
  216. Newman DL, Moffitt TE, Caspi A, Magdol L, Silva PA, Stanton WR. Psychiatric disorder in a birth cohort of young adults: Prevalence, comorbidity, clinical significance, and new case incidence from ages 11 to 21. Journal of Consulting and Clinical Psychology. 1996;64:552–562. [PubMed] [Google Scholar]
  217. Nolan CL, Moore GJ, Madden R, Farchione T, Bartoi M, Lorch E, Stewart CM, Rosenberg DR. Prefrontal cortical volume in childhood-onset major depression: Preliminary findings. Archives of General Psychiatry. 2002;59:173–179. doi: 10.1001/archpsyc.59.2.173. [DOI] [PubMed] [Google Scholar]
  218. Nolen-Hoeksema S. Responses to depression and their effects on the duration of depressive episodes. Journal of Abnormal Psychology. 1991;100:569–582. doi: 10.1037//0021-843x.100.4.569. [DOI] [PubMed] [Google Scholar]
  219. Nolen-Hoeksema S, Girgus JS, Seligman ME. Learned helplessness in children: A longitudinal study of depression, achievement, and explanatory style. Journal of Personality & Social Psychology. 1986;51:435–442. doi: 10.1037//0022-3514.51.2.435. [DOI] [PubMed] [Google Scholar]
  220. Nolen-Hoeksema S, Girgus JS, Seligman ME. Predictors and consequences of childhood depressive symptoms: A 5-year longitudinal study. Journal of Abnormal Psychology. 1992;101:405–422. doi: 10.1037//0021-843x.101.3.405. [DOI] [PubMed] [Google Scholar]
  221. Nylander PO, Engström C, Chotai J, Wahlström J, Adolfsson R. Anticipation in Swedish families with bipolar affective disorder. Journal of Medical Genetics. 1994;31:686–689. doi: 10.1136/jmg.31.9.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Ochsner KN. Current directions in social cognitive neuroscience. Current Opinion in Neurobiology. 2004;14:254–248. doi: 10.1016/j.conb.2004.03.011. [DOI] [PubMed] [Google Scholar]
  223. Ohara K, Suzuki Y, Ushimi Y, Yoshida K, Ohara K. Anticipation and imprinting in Japanese familial mood disorders. Psychiatry Research. 1998;79:191–198. doi: 10.1016/s0165-1781(98)00045-6. [DOI] [PubMed] [Google Scholar]
  224. Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cerebral Cortex. 2000;10:206–219. doi: 10.1093/cercor/10.3.206. [DOI] [PubMed] [Google Scholar]
  225. Oquendo MA, Barrera A, Ellis SP, Li S, Burke AK, Grunebaum M. Instability of symptoms in recurrent major depression: A prospective study. American Journal of Psychiatry. 2004;161:255–261. doi: 10.1176/appi.ajp.161.2.255. [DOI] [PubMed] [Google Scholar]
  226. Orvaschel H, Walsh-Allis G, Ye WJ. Psychopathology in children of parents with recurrent depression. Journal of Abnormal Child Psychology. 1988;16:17–28. doi: 10.1007/BF00910497. [DOI] [PubMed] [Google Scholar]
  227. Peterson C, Maier S, Seligman MEP. Learned helplessness. New York: NY: Oxford; 1993. [Google Scholar]
  228. Pocock SJ. Clinical trials: A practical approach. New York: NY: John Wiley & Sons; 1983. [Google Scholar]
  229. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorders. American Journal of Psychiatry. 1992;149:999–1010. doi: 10.1176/ajp.149.8.999. [DOI] [PubMed] [Google Scholar]
  230. Price JL, Carmichael ST, Drevets WC. Networks related to the orbital and medial prefrontal cortex: A substrate for emotional behavior? Progress in Brain Research. 1996;107:523–536. doi: 10.1016/s0079-6123(08)61885-3. [DOI] [PubMed] [Google Scholar]
  231. Puig-Antich J. Major depression and conduct disorder in prepuberty. Journal of the American Academy of Child Psychiatry. 1982;21:118–128. doi: 10.1016/s0002-7138(09)60910-9. [DOI] [PubMed] [Google Scholar]
  232. Puig-Antich J. Psychobiological markers: Effect of age and puberty. In: Rutter M, Izard CE, Read PB, editors. Depression in young people: Developmental and clinical perspectives. New York: NY: Guilford Press; 1986a. pp. 341–348. [Google Scholar]
  233. Puig-Antich J. Biological factors in prepubertal major depression. Pediatric Annals. 1986b;15:870–872. doi: 10.3928/0090-4481-19861201-09. [DOI] [PubMed] [Google Scholar]
  234. Puig-Antich J, Dahl R, Ryan N, Novacenko H, Goetz D, Goetz R, Twomey J, Klepper T. Cortisol secretion in prepubertal children with major depressive disorder. Archives of General Psychiatry. 1989;46:801–809. doi: 10.1001/archpsyc.1989.01810090043008. [DOI] [PubMed] [Google Scholar]
  235. Puig-Antich J, Goetz D, Davies M, Kaplan T, Davies S, Ostrow L, Asnis L, Twomey J, Iyengar S, Ryan ND. A controlled family history study of prepubertal major depressive disorder. Archives of General Psychiatry. 1989;46:406–418. doi: 10.1001/archpsyc.1989.01810050020005. [DOI] [PubMed] [Google Scholar]
  236. Puig-Antich J, Lukens E, Davies M, Goetz D, Brennan-Quattrock J, Todak G. Psychosocial functioning in prepubertal major depressive disorders. I: Interpersonal relationships during the depressive episode. Archives of General Psychiatry. 1985a;42:500–507. doi: 10.1001/archpsyc.1985.01790280082008. [DOI] [PubMed] [Google Scholar]
  237. Puig-Antich J, Lukens E, Davies M, Goetz D, Brennan-Quattrock J, Todak G. Psychosocial functioning in prepubertal major depressive disorders. II: Interpersonal relationships after sustained recovery from affective episode. Archives of General Psychiatry. 1985b;42:511–517. doi: 10.1001/archpsyc.1985.01790280093010. [DOI] [PubMed] [Google Scholar]
  238. Puig-Antich J, Perel JM, Lupatkin W, Chambers WJ, Tabrizi MA, King J, Goetz R, Davies M, Stiller RL. Imipramine in prepubertal major depressive disorders. Archives of General Psychiatry. 1987;44:81–89. doi: 10.1001/archpsyc.1987.01800130093012. [DOI] [PubMed] [Google Scholar]
  239. Quiggle NL, Garber J, Panak WF, Dodge KA. Social information processing in aggressive and depressed children. Child Development. 1992;63:1305–1320. [PubMed] [Google Scholar]
  240. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, Sotckmeier CA. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry. 1999;45:1085–1098. doi: 10.1016/s0006-3223(99)00041-4. [DOI] [PubMed] [Google Scholar]
  241. Rao U, Dahl RE, Ryan ND, Birmaher B, Williamson DE, Rao R, Kaufman J. Heterogeneity in EEG sleep findings in adolescent depression: Unipolar versus bipolar clinical course. Journal of Affective Disorders. 2002;70:273–280. doi: 10.1016/s0165-0327(01)00396-2. [DOI] [PubMed] [Google Scholar]
  242. Rao U, Ryan ND, Birmaher B, Dahl RE, Williamson DE, Kaufman J, Rao R, Nelson B. Unipolar depression in adolescents: Clinical outcome in adulthood. Journal of the American Academy of Child and Adolescent Psychiatry. 1995;34:566–578. doi: 10.1097/00004583-199505000-00009. [DOI] [PubMed] [Google Scholar]
  243. Rolls ET. The functions of the orbitofrontal cortex. Brain and Cognition. 2004;55:11–29. doi: 10.1016/S0278-2626(03)00277-X. [DOI] [PubMed] [Google Scholar]
  244. Romeo RD. Neuroendocrine and behavioral development during puberty: A tale of two axes. Vitamins and Hormones. 2005;71:1–25. doi: 10.1016/S0083-6729(05)71001-3. [DOI] [PubMed] [Google Scholar]
  245. Roosa MW, Reinholtz C, Angelini PJ. The relation of child sexual abuse and depression in young women: Comparisons across four ethnic groups. Journal of Abnormal Child Psychology. 1999;27:65–76. [PubMed] [Google Scholar]
  246. Rosso IM, Cintron CM, Steingard RJ, Renshaw PF, Young AD, Yurgelun-Todd DA. Amygdala and hippocampus volumes in pediatric major depression. Biological Psychiatry. 2005;57:21–26. doi: 10.1016/j.biopsych.2004.10.027. [DOI] [PubMed] [Google Scholar]
  247. Rush AJ, Feldman-Koffler F, Weissenburger JE, Giles DE, Roffwarg HP, Orsulak PJ. Depressive spectrum disease with and without depression in first degree relatives. Journal of Affective Disorders. 1995;35:131–138. doi: 10.1016/0165-0327(95)00057-7. [DOI] [PubMed] [Google Scholar]
  248. Rutter M, editor. Psychosocial disturbances in young people: Challenges for prevention. New York: NY: Cambridge University Press; 1995. [Google Scholar]
  249. Ryan ND. Medication treatment for depression in children and adolescents. CNS Spectrums. 2003a;8:283–287. doi: 10.1017/s1092852900018496. [DOI] [PubMed] [Google Scholar]
  250. Ryan ND. Child and adolescent depression: Short-term treatment effectiveness and long-term opportunities. International Journal of Methods in Psychiatry Research. 2003b;12:44–53. doi: 10.1002/mpr.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  251. Ryan ND, Birmaher B, Perel JM, Dahl RE, Meyer V, al-Shabbout M, Iyengar S, Puig-Antich J. Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression: Depressed vs. normal children. Archives of General Psychiatry. 1992;49:843–851. doi: 10.1001/archpsyc.1992.01820110007001. [DOI] [PubMed] [Google Scholar]
  252. Ryan ND, Dahl RE, Birmaher B, Williamson DE, Iyengar S, Nelson B, Puig-Antich J, Perel JM. Stimulatory tests of growth hormone secretion in prepubertal major depression: Depression versus normal children. Journal of the American Academy of Child and Adolescent Psychiatry. 1994;33:824–833. doi: 10.1097/00004583-199407000-00008. [DOI] [PubMed] [Google Scholar]
  253. Ryan ND, Puig-Antich J, Ambrosini P, Rabinovich H, Robinson D, Nelson B, Iyengar S, Twomey J. The clinical picture of major depression in children and adolescents. Archives of General Psychiatry. 1987;44:854–861. doi: 10.1001/archpsyc.1987.01800220016003. [DOI] [PubMed] [Google Scholar]
  254. Sanches M, Sassi RB, Axelson D, Nicoletti M, Brambilla P, Hatch JP, Keshavan MS, Ryan ND, Birmaher B, Soare JC. Subgenual prefrontal cortex of child and adolescent bipolar patients: A morphometric magnetic resonance imaging study. Psychiatry Research: Neuroimaging. 2005;138:43–49. doi: 10.1016/j.pscychresns.2004.11.004. [DOI] [PubMed] [Google Scholar]
  255. Sasaki-Adams DM, Kelley AE. Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior. Neuropsychopharmacology. 2001;25:440–452. doi: 10.1016/S0893-133X(01)00240-8. [DOI] [PubMed] [Google Scholar]
  256. Scharfman HE, MacLusky NJ. Similarities between actions of estrogen and BDNF in the hippocampus: Coincidence or clue? Trends in Neuroscience. 2005;28:79–85. doi: 10.1016/j.tins.2004.12.005. [DOI] [PubMed] [Google Scholar]
  257. Schmidt LA, Schulkin J. Toward a computational affective neuroscience. Brain and Cognition. 2000;42:95–98. doi: 10.1006/brcg.1999.1172. [DOI] [PubMed] [Google Scholar]
  258. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, Schulze TG, Deschner M, Schmäl C, Höfels S, Zobel A, Illig T, Propping P, Holsboer F, Rietschel M, Nöthen MM, Cichon S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biological Psychiatry. 2005;58:307–314. doi: 10.1016/j.biopsych.2005.04.006. [DOI] [PubMed] [Google Scholar]
  259. Schwartz CE, Dorer DJ, Beardslee WR, Lavori PW, Keller MB. Maternal expressed emotion and parental affective disorder: Risk for childhood depressive disorder, substance abuse, or conduct disorder. Journal of Psychiatric Research. 1990;24:231–250. doi: 10.1016/0022-3956(90)90013-g. [DOI] [PubMed] [Google Scholar]
  260. Seligman MEP, Reivich K, Jaycox L, Gillham J. The optimistic child. Boston, MA: Houghton Mifflin Co; 1995. [Google Scholar]
  261. Shain BN, King CA, Naylor M, Alessi N. Chronic depression and hospital course in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 1991;30:428–433. doi: 10.1097/00004583-199105000-00012. [DOI] [PubMed] [Google Scholar]
  262. Shaw DS, Vondra JI. Infant attachment security and maternal predictors of early behavior problems: A longitudinal study of low-income families. Journal of Abnormal Child Psychology. 1995;23:335–357. doi: 10.1007/BF01447561. [DOI] [PubMed] [Google Scholar]
  263. Sheeber L, Allen N, Davis B, Sorensen E. Regulation of negative affect during mother-child problem-solving interactions: Adolescent depressive status and family processes. Journal of Abnormal Child Psychology. 2000;28:467–479. doi: 10.1023/a:1005135706799. [DOI] [PubMed] [Google Scholar]
  264. Sheeber L, Hops H, Davis B. Family processes in adolescent depression. Clinical Child and Family Psychology Review. 2001;4:19–35. doi: 10.1023/a:1009524626436. [DOI] [PubMed] [Google Scholar]
  265. Sheeber L, Sorensen E. Family relationships of depressed adolescents: A multimethod assessment. Journal of Clinical Child Psychology. 1998;27:268–277. doi: 10.1207/s15374424jccp2703_4. [DOI] [PubMed] [Google Scholar]
  266. Shelton RC. Cellular mechanisms in the vulnerability to depression and response to antidepressants. Psychiatry Clinics of North America. 2000;23:713–729. doi: 10.1016/s0193-953x(05)70193-3. [DOI] [PubMed] [Google Scholar]
  267. Sherrill JT, Kovacs M. Nonsomatic treatment of depression. Psychiatric Clinics of North America. 2004;27:139–154. doi: 10.1016/S0193-953X(03)00115-1. [DOI] [PubMed] [Google Scholar]
  268. Sherrill JT, Kovacs M. Interview schedule for children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39:67–75. doi: 10.1097/00004583-200001000-00018. [DOI] [PubMed] [Google Scholar]
  269. Shochet IM, Dadds MR, Holland D, Whitefield K, Harnett PH, Osgarby SM. The efficacy of a universal school-based program to prevent adolescent depression. Journal of Clinical Child Psychology. 2001;30:303–315. doi: 10.1207/S15374424JCCP3003_3. [DOI] [PubMed] [Google Scholar]
  270. Shonkoff JP. Science, policy, and practice: Three cultures in search of a shared mission. Child Development. 2000;71:181–187. doi: 10.1111/1467-8624.00132. [DOI] [PubMed] [Google Scholar]
  271. Shonkoff JP. From neurons to neighborhoods: Old and new challenges for developmental and behavioral pediatrics. Journal of Developmental Behavioral Pediatrics. 2003;24:70–76. doi: 10.1097/00004703-200302000-00014. [DOI] [PubMed] [Google Scholar]
  272. Sisk CL, Foster DL. The neural basis of puberty and adolescence. Nature Neuroscience. 2004;7:1040–1047. doi: 10.1038/nn1326. [DOI] [PubMed] [Google Scholar]
  273. Steingard RJ. The neuroscience of depression in adolescence. Journal of Affective Disorders. 2000;61:15–21. doi: 10.1016/s0165-0327(00)00285-8. [DOI] [PubMed] [Google Scholar]
  274. Steiger A, Holsboer F. Neuropeptides and human sleep. Sleep. 1997a;20:1038–1052. [PubMed] [Google Scholar]
  275. Steiger A, Holsboer F. Nocturnal secretion of prolactin and cortisol and the sleep EEG in patients with major endogenous depression during an acute episode and after full remission. Psychiatry Research. 1997b;72:81–88. doi: 10.1016/s0165-1781(97)00097-8. [DOI] [PubMed] [Google Scholar]
  276. Steingard RJ, Renshaw PF, Hennen J, Lenox M, Cintron CB, Young AD, Connor DF, Au TH, Yurgelun-Todd DA. Smaller frontal lobe white matter volumes in depressed adolescents. Biological Psychiatry. 2002;52:413–417. doi: 10.1016/s0006-3223(02)01393-8. [DOI] [PubMed] [Google Scholar]
  277. Steingard RJ, Renshaw PF, Yurgelun-Todd D, Appelmans KE, Lyoo IK, Shorrock KL, Bucci JP, Cesena M, Abebe D, Zurakowski D, Poussaint TY, Barnes P. Structural abnormalities in brain magnetic resonance images of depressed children. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:307–311. doi: 10.1097/00004583-199603000-00011. [DOI] [PubMed] [Google Scholar]
  278. Strauss J, Barr CL, George CJ, Devlin B, Vetró Á, Kiss E, Baji I, King N, Shaikh S, Lanktree M, Kovacs M, Kennedy JL. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: Confirmation in a Hungarian sample. Molecular Psychiatry. 2005 doi: 10.1038/sj.mp.4001685. In Press. [DOI] [PubMed] [Google Scholar]
  279. Strauss J, Barr CL, George CJ, King N, Shaikh S, Devlin B, Kovacs M, Kennedy JL. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 2004;131B:16–19. doi: 10.1002/ajmg.b.30041. [DOI] [PubMed] [Google Scholar]
  280. Strober M, Lampert C, Schmidt S, Morrell W. The course of major depressive disorder in adolescents. I: Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes. Journal of the American Academy of Child and Adolescent Psychiatry. 1993;32:34–42. doi: 10.1097/00004583-199301000-00006. [DOI] [PubMed] [Google Scholar]
  281. Stroud LR, Papandonatos GD, Williamson DE, Dahl RE. Sex differences in the effects of pubertal development on responses to a corticotropin-releasing hormone challenge: The Pittsburgh psychobiologic studies. Annals of the New York Academy of Science. 2004;1021:348–351. doi: 10.1196/annals.1308.043. [DOI] [PubMed] [Google Scholar]
  282. Stroud LR, Salovey P, Epel ES. Sex differences in stress responses: Social rejection versus achievement stress. Biological Psychiatry. 2002;52:318–327. doi: 10.1016/s0006-3223(02)01333-1. [DOI] [PubMed] [Google Scholar]
  283. Surgeon General. National action agenda for children’s mental health. 2001 doi: 10.1007/s11920-002-0042-5. [On-line, Retrieved 2/3/02]. Available: http://www.surgeongeneral.gov/cmh/childreport.htm. [DOI] [PubMed]
  284. Surgeon General. Mental health: A report of the surgeon general. 1999 [On-line, Retrieved 2/3/02]. Available: http://www.surgeongeneral.gov/library/mentalhealth.
  285. Thapar A, McGuffin P. A twin study of depression in childhood. British Journal of Psychiatry. 1994;165:259–265. doi: 10.1192/bjp.165.2.259. [DOI] [PubMed] [Google Scholar]
  286. Thoenen H. Neurotrophins and neuronal plasticity. Science. 1995;270:593–598. doi: 10.1126/science.270.5236.593. [DOI] [PubMed] [Google Scholar]
  287. Thomas KM, Drevets WC, Dahl RE, Ryan ND, Birmaher B, Eccard CH, Axelson D, Whalen PJ, Casey BJ. Amygdala response to fearful faces in anxious and depressed children. Archives of General Psychiatry. 2001;58:1057–1063. doi: 10.1001/archpsyc.58.11.1057. [DOI] [PubMed] [Google Scholar]
  288. Todd RD, Neuman R, Geller B, Fox LW, Hickok J. Genetic studies of affective disorder: Should we be starting with childhood onset probands? Journal of the American Academy of Child and Adolescent Psychiatry. 1993;32:1164–1171. doi: 10.1097/00004583-199311000-00008. [DOI] [PubMed] [Google Scholar]
  289. Tomarken AJ, Dichter GS, Garber J, Simien C. Resting frontal brain activity: Linkages to maternal depression and socio-economic status among adolescents. Biological Psychology. 2004;67:77–102. doi: 10.1016/j.biopsycho.2004.03.011. [DOI] [PubMed] [Google Scholar]
  290. Tomarken AJ, Keener-Miller A. Frontal brain asymmetry and depression: A self-regulatory perspective. Cognition and Emotion. 1998;12:387–420. [Google Scholar]
  291. Tremblay LK, Naranjo CA, Cardenas L, Herrmann N, Busto UE. Probing brain reward system function in major depressive disorder: Altered response to dextroamphetamine. Archives of General Psychiatry. 2002;59:409–416. doi: 10.1001/archpsyc.59.5.409. [DOI] [PubMed] [Google Scholar]
  292. Tsai S. Possible involvement of the BDNF-dependent pathway in treatment-emergent suicidality or decreased response to antidepressants. Medical Hypotheses. 2005 doi: 10.1016/j.mehy.2005.05.010. In Press. [DOI] [PubMed] [Google Scholar]
  293. Vincent JB, Kovacs M, Krol R, Barr CL, Kennedy JL. Intergenerational CAG repeat expansion at ERDA1 in a family with childhood-onset depression, schizoaffective disorder, and recurrent major depression. American Journal of Medical Genetics. 1999;88:79–82. [PubMed] [Google Scholar]
  294. Vincent JB, Neves-Pereira ML, Paterson AD, Yamamoto E, Parikh SV, Macciardi F, Gurling HM, Potkin SG, Pato CN, Macedo A, Kovacs M, Davies M, Lieberman JA, Meltzer HY, Petronis A, Kennedy JL. An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: A common expansion locus. American Journal of Human Genetics. 2000;66:819–829. doi: 10.1086/302803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  295. Vostanis P, Feehan C, Grattan E, Bickerton WL. Treatment for children and adolescents with depression: Lessons from a controlled trial. Clinical Child Psychology and Psychiatry. 1996;1:199–212. [Google Scholar]
  296. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, Childress A, Donnelly C, Deas D. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. Journal of the American Medical Association. 2003;290:1033–1041. doi: 10.1001/jama.290.8.1033. [DOI] [PubMed] [Google Scholar]
  297. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu H, Joyce PR, Karam EG, Lee C, Lellouch J, Lepine J, Neuman SC, Rubio-Stipec M, Wells E, Wickramaratne PJ, Wittchen H, Yeh E. Cross-national epidemiology of major depression and bipolar disorder. Journal of the American Medical Association. 1996;276:293–299. [PubMed] [Google Scholar]
  298. Weissman MM, Warner V, Wickramaratne P, Moreau D, Olfson M. Offspring of depressed parents: 10 years later. Archives of General Psychiatry. 1997;54:932–940. doi: 10.1001/archpsyc.1997.01830220054009. [DOI] [PubMed] [Google Scholar]
  299. Werry JS, Biederman J, Thisted R, Greenhill L, Ryan N. Resolved: Cardiac arrhythmias make desipramine an unacceptable choice in children. Journal of the American Academy of Child and Adolescent Psychiatry. 1995;34:1239–1245. doi: 10.1097/00004583-199509000-00023. [DOI] [PubMed] [Google Scholar]
  300. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet. 2004;363:1341–1345. doi: 10.1016/S0140-6736(04)16043-1. [DOI] [PubMed] [Google Scholar]
  301. Wickramaratne PJ, Greenwald S, Weissman MM. Psychiatric disorders in the relatives of probands with prepubertal-onset or adolescent-onset major depression. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39:1396–1405. doi: 10.1097/00004583-200011000-00014. [DOI] [PubMed] [Google Scholar]
  302. Wickramaratne PJ, Warner V, Weissman MM. Selecting early onset MDD probands for genetic studies: Results from a longitudinal high-risk study. American Journal of Medical Genetics. 2000;96:93–101. [PubMed] [Google Scholar]
  303. Wickramaratne PJ, Weissman MM. Onset of psychopathology in offspring by developmental phase and parental depression. Journal of the American Academy of Child and Adolescent Psychiatry. 1998;37:933–942. doi: 10.1097/00004583-199809000-00013. [DOI] [PubMed] [Google Scholar]
  304. Williams S, Anderson J, McGee R, Silva PA. Risk factors for behavioral and emotional disorders in preadolescent children. Journal of the American Academy of Child and Adolescent Psychiatry. 1990;29:413–419. doi: 10.1097/00004583-199005000-00013. [DOI] [PubMed] [Google Scholar]
  305. Williamson DE, Ryan ND, Birmaher B, Dahl RE, Kaufman J, Rao U, Puig-Antich J. A case-control family history study of depression in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 1995;34:1596–1607. doi: 10.1097/00004583-199512000-00010. [DOI] [PubMed] [Google Scholar]
  306. Williamson DE, Birmaher B, Axelson DA, Ryan ND, Dahl RE. First episode of depression in children at low and high familial risk for depression. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:291–297. doi: 10.1097/00004583-200403000-00010. [DOI] [PubMed] [Google Scholar]
  307. Wood A, Harrington R, Moore A. Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders. Journal of Child Psychology and Psychiatry. 1996;37:737–746. doi: 10.1111/j.1469-7610.1996.tb01466.x. [DOI] [PubMed] [Google Scholar]
  308. Yorbik O, Birmaer B, Axelson D, Williamson DE, Ryan ND. Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder. Journal of Clinical Psychiatry. 2004;65:1654–1659. doi: 10.4088/jcp.v65n1210. [DOI] [PubMed] [Google Scholar]
  309. Young EA. Sex differences in the HPA Axis: Implications for psychiatric disease. Journal of Gender Specific Medicine. 1998;1:21–27. [PubMed] [Google Scholar]
  310. Zahn-Waxler C, Iannotti RJ, Cummings EM, Denham S. Antecedents of problem behaviors in children of depressed mothers. Development and Psychopathology. 1990;2:271–291. [Google Scholar]
  311. Zlochower A, Cohn JF. Vocal timing in face-to-face interactions of clinically depressed and nondepressed mothers and their 4-month-old infants. Infant Behavior and Development. 1996;19:373–376. [Google Scholar]
  312. Zubenko GS, Hughes HB, Maher BS, Stiffler JS, Zubenko WN, Marazita ML. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. American Journal of Medical Genetics. 2002;114:980–987. doi: 10.1002/ajmg.b.10933. [DOI] [PubMed] [Google Scholar]
  313. Zubenko GS, Maher B, Hughes HB, Zubenko WN, Stiffler JS, Kaplan BB, Marazita ML. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. American Journal of Medical Genetics. 2003;15:1–18. doi: 10.1002/ajmg.b.20073. [DOI] [PubMed] [Google Scholar]

RESOURCES